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Obsessive  Compulsive  Disorder (OCD) is a  wel-known and serious  mental  disorder.  Despite 
general public awareness or the  disorder, it is  often taken lightly and  with a humor it  does  not 
deserve. Most probably, such out-of-place humor can be tracked to pop-culture representations of 
this disorder (Sheldon  Cooper from  Big  Bang Theory  or  Hercule  Poirot from a  wel-known 
British series). OCD is one of the leading causes of disability, and has an immense impact on the 
welbeing  of both  OCD  patients and their families and friends.  There are several successful 
treatments that reduce OCD symptoms, but not many cure  OCD completely. Discovery of such 
treatments has been delayed by a lack of understanding of the disorder, and prevention is hindered 
by obliviousness to direct causes. As with many mental diseases, there are only rare times when a 
cause of a mental disease can be confidently identified, and causes often go unnoticed or are not 
even noticeable. Animal models are thus indispensable in alowing us to controlably reproduce a 
suspected insult and observe behavioral and neurophysiological changes that folow.  
By serendipitous coincidence, two seemingly unrelated lines of research are underway in 
our laboratory that converge in this thesis – basic research on memory function and translational 
research  on animal  models of  psychiatric  disorders.  Without this concurence, it is  unlikely my 
work on OCD would lead to my findings regarding hippocampal deficiency in an animal model of 
OCD. 
Methodologies and results described here are not in chronological order. Experiments presented 
as first  were actualy conducted last based on results from the later two studies. Yet, I thought 
that this  order would be  more  digestible for the reader.  Hopefuly, this  minor alteration for the 
sake of the story is not punishable. 
What folows is general information about Obsessive  Compulsive  Disorder – its  variability, 
proposed causes and  description  of the animal  model that this  work  was conducted  on. 
Knowledge gaps wil also be described. It is possible that a more knowledgeable reader than I wil 
find a simpler and more fiting explanation of our findings. But, it is possible that there may be 
some substance to hypotheses proposed here – because when observing neuropsychiatric diseases 
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Obsessive-compulsive disorder (OCD) is a serious psychiatric condition  manifested by repeated 
thoughts folowed  by stereotypic compulsive  behavior. Alterations to cortico-thalamo-striato-
cortical circuits are most  often implicated in the pathophysiology  of OCD.   However,  many 
studies have also found a changed  volume, shape and activity  of the hippocampus in  OCD 
patients.  This  work focused  on the activity  of  hippocampal  CA1 cels during stereotypical 
checking behavior and on cognitive flexibility in a quinpirole (QNP) sensitization model of OCD. 
The activity  of  CA1  hippocampal cels  during stereotypical checking was assessed in an 
enriched open-field test in QNP sensitized rats. Arc+ (activity‐regulated cytoskeletal associated 
protein,  or  Arg  3.1) mRNA expression  profiles were  determined in  CA1 coronal  hippocampal 
sections folowing stereotypical checking.  After the establishment  of stereotypical checking (10 
sessions), rats were exposed to the arena and sacrificed after 5 minutes. QNP sensitized animals 
visited the same objects with the same frequency as during previous sessions, while control rats 
did  not.  Locomotor activity  was comparable  between  QNP treated rats and controls.  Folowing 
sacrifice, rat brains were flash frozen and sliced to 20 µm thick sections. Sections, mounted on 
slides, were hybridized with anti-Arc riboprobes, and visualized using tyramid amplification. Both 
control rats and rats treated  with  QNP  displayed low  baseline Arc+  positive cels in  CA1. 
Importantly, there was a significant interaction between QNP and the environment – QNP treated 
rats  displayed a lower number  of Arc+  nuclei in CA1  during exploring/checking the  open-field 
compared to control rats;  while in the  baseline condition there  was  no significant  diference in 
Arc+ cels in CA1 between QNP treated rats and control rats. 
To assess cognitive flexibility, a  hippocampus-dependent  Carousel arena task with 
reversal  was employed.  Animals  were to avoid a sector  on rotating arena that was not directly 
perceptible and could only be localized by spatial relationships to distal landmarks. The number 
of entrances into the sector was used as a measure of learning. Rats treated with QNP displayed a 
severe, but transient, increase in the number of erors in reversal. Treatment with clomipramine, a 
drug commonly  used to treat  OCD, further impaired reversal and impaired acquisition of the 
Carousel arena task. On the other hand, a combination of clomipramine and risperidone improved 
the rats’  performance. Furthermore, two-way active avoidance task confirmed  hippocampal 
impairment in QNP treated rats. 
Although  direct causality cannot  be infered from present results, this work  highlights the 
possibility of hippocampal involvement in generation of stereotypical behavior similar to behavior 









Obsedantně  kompulzivní  porucha (OCD) je závažné  psychiatrické  onemocnění,  které se 
projevuje  opakovanými  nutkavými  myšlenkami a  následně stereotypním  kompulzivním 
chováním.  Do  patofyziologie  OCD jsou zapojeny změny  kortiko-thalamo-striato-kortikálních 
obvodů. Mnoho studií však také zjistilo změněný objem, tvar a aktivitu hipokampu u pacientů s 
OCD.  Tato  práce  byla zaměřena  na aktivitu  hipokampálních  CA1  buněk  během stereotypního 
kontrolního chování  podobného  kompulzivní  kontrole a  na  kognitivní flexibilitu  v potkaním 
modelu sensitizace dopaminovim D2 agonistem quinpirolem (QNP). 
U sensitizovaných  potkanů a  kontrol  byla  hodnocena aktivita  hipokampálních  buněk 
v oblasti CA1 během stereotypní kontroly v otevřeném poli s vloženými objekty. Stanovili jsme 
profily exprese ranneho genu Arc+ (aktivitou regulovaného cytoskeletálního proteinu neboli Arg 
3.1) v koronálních hipokampálních řezech v oblasti CA1. Po ustavení stereotypního kontrolovani 
(10 sezení) byli potkani vystaveni aréně a přesně po 5 minutách humánně usmrceni. Sensitizovaná 
zvířata navštěvovala konkrétní objekty v jednotlivých sezeních s konsistentní preferencí, zatímco 
kontrolní tuto  preferenci  měnila  od jednoho sezení  k  druhému.  Lokomoční aktivita  byla 
v testovacím sezení  mezi  oběma skupinami srovnatelná.  Po  usmrcení  byly  mozky  potkanů 
bleskově zmrazeny a  nakrájeny na řezy o tloušťce 20µm. Řezy na sklíčkách byly inkubovány s 
anti-Arc probami a exprese  byla  vizualizována  pomocí tyramidové amplifikace. Jak  kontrolní 
skupina, tak potkani sensitizovaní QNP, kteří nebyli vystaveni prostředí, vykazovali bazální nízké 
počty Arc+ buněk v CA1. Důležité je, že došlo k významné interakci mezi QNP a prostředím – 
potkani sensitizovaní  pomocí  QNP  vykazovaly  nižší  počet Arc+ jader  v  CA1  během 
explorace/kontroly otevřeného pole ve srovnání s kontrolními potkany při této exploraci. 
Pro  otestování  kognitivní flexibility  byla  použita  úloha aktivního  vyhýbání se  místu 
s přeučením na rotující aréně (Kolotoči) závislá na hipokampu. Zvířata se měla za úkol vyhýbat 
sektoru na rotující aréně, který nebyl přímo viditelný, a jehož polohu šlo určit pouze prostorovými 
vztahy  vůči  vzdáleným  orientačním  bodům.  Počet  vstupů  do tohoto sektoru  byl  použit jako 
měřítko učení a flexibility. Potkani vystavení QNP vykazovali významné, ale přechodné zvýšení 
počtu chyb  při  přeučení.  Léčba  klomipraminem, léčivem  běžně  používaným  k terapi  OCD, 
zhoršila počáteční učení i přeučení na rotující aréně. Na druhou stranu kombinace klomipraminu a 
risperidonu zachovala výkonnost potkanů na úrovni kontrol. Kromě toho výsledky z neprostorové 
úlohy aktivního  obousměrného  vyhýbání se (two-way active avoidance) také  podpořily  koncept 
narušení hipokampu u potkanů sensitizovaných QNP. 
Ačkoli z  dosavadních  výsledků  nelze  odvodit  přímou  příčinnou souvislost, tato  práce 
zdůrazňuje  možnost  klíčové role  hipokampu  při  vytváření stereotypního chování  podobného 






3 INTRODUCTION  
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3.1 About obsessive-compulsive disorder 
Every so often, people are uncertain if they turned of appliances or locked doors. And every so 
often they go and check if they realy  did.  However,  when these and similar thoughts and 
checking behaviors cross a certain threshold, a person is suspected of sufering from Obsessive-
Compulsive  Disorder (OCD). In fact, OCD is relatively common – it is the  4th most frequent 
psychiatric disorder, with a lifetime prevalence  of about 1-3% (Ruscio et al., 2010; Wahl et al., 
2010). OCD is characterized by two groups of often-complementary symptoms – obsessions and 
compulsions. Obsessions are characterized by uncontrolable intrusive thoughts. The contents of 
obsessive thoughts are mostly idiosyncratic, although there are recurrent themes of ‘security’ 
(Woody and  Szechtman,  2011).  Specificaly,  obsessions  often include  fears  of contamination, 
robbery,  household fires or  other  harm coming to ones self  or  others (Wiliams et al.,  2013). 
Obsessions are  often folowed  by compulsive  behaviors that ofer temporary relief (Van 
Schalkwyk et al.,  2016), and these compulsions are  often the  only  visible symptoms  of OCD. 
Similarly to obsessions, compulsions are very individual and range from invisible mental acts to 
complex physical rituals (Sibrava et al., 2011). Common compulsions include washing, checking, 
ordering and counting. 
3.2 Symptom dimensions 
Although the manifestations of OCD are easily graspable, more systematic analyses of symptoms 
are necessary for scientific research.  Cluster analyses have indicated that  paterns in the above-
described  OCD symptoms can  be  broken  down into classes,  or symptom  dimensions of 
obsessions and compulsions, which often occur together (Wiliams et al., 2013). Four main OCD 
dimensions are recognized  – contamination/cleaning; checking/aggressive thoughts; 
symmetry/ordering; and sexual/religious thoughts (Leckman et al.,  2010).  Analyses that have 
been used to cluster these symptom dimensions have yielded very consistent results across studies 
(Bloch et al., 2008). Throughout a lifetime, symptom dimensions usualy stay constant, although 
changes of symptoms within one dimension can occur (Skoog and Skoog, 1999; Mataix-Cols et 
al., 2002). 
 
3.3 Age of onset 
Heterogeneity in OCD is also apparent in the age of onset. Based on the time of first symptom 
manifestation, patients can  be  divided into two subgroups: an adult-onset subgroup, where 
symptoms appear approximately at the age of twenty, and a pediatric subgroup, where first 
symptoms occur when a patient is around 8-12 years old (Heyman et al., 2001). Pediatric patients 
account for 30-50% of OCD cases (Zohar, 1999), and they display similar types and intensities of 
symptoms as adult onset patients (Delorme et al., 2005), with the exception of a slight increase in 
compulsions  unaccompanied  by  obsessions in the pediatric  patient  group (Swedo et al.,  2004). 
Males and females are equaly affected in adult  onset patients,  but  boys are  more commonly 
afected in  pediatric cases (Geler,  2006).  Moreover,  OCD  has a  more abrupt  onset in  pediatric 
patients (Swedo et al.,  2004). In conclusion,  despite symptom similarities, there are several 






Various comorbid diseases often burden OCD patients. Of these, the most common are anxiety, 
depression, tics, social phobia and eating disorders (Toresan et al., 2013). Conversely, obsessive 
and compulsive symptoms are often a comorbidity of other psychiatric disorders, such as Tourete 
syndrome, Sydenham’s chorea (Hounie et al., 2004), trichotilomania (Keuthen et al., 2016) and 
schizophrenia (Veras et al., 2017).  In fact, Tourete syndrome is present in 30% of OCD cases 
(Sinopoli et al.,  2017). Importantly, it appears that  many comorbid  disorders  do  not arise as a 
consequence  of each  other  but are due to common  genetic etiology.  For example,  Tourete 
syndrome is  geneticaly  very closely related to  OCD (Ferrão et al.,  2009).  As shown  by twin 
studies, shared  genetic factors  between  OCD and  depression account for the close relationship 
between the two diseases (Bolhuis et al., 2014). This notion is also supported by the eficiency of 
selective serotonin reuptake inhibitors (SSRIs) in both OCD and depression (Murphy et al., 2008). 
 
3.5 Causes of OCD 
Several  diferent causes of  OCD  have  been  proposed. In  many cases it is  presumed that 
environmental factors are responsible for the development  of  OCD. The  most commonly 
discussed of these are life traumas and streptococcal infections. However, genetic predispositions 
make people more vulnerable to developing certain conditions folowing environmental triggers. 
It is estimated that genetic factors account for at least 48% of the variance of OCD (Browne et al., 
2014; Monzani et al., 2014). 
 
3.5.1 Environmental factors 
Two  known environmental factors associated  with  OCD are life traumas and streptococcal 
infections.  Traumas are related to  OCD in  both  pediatric and adult  onset  OCD,  while 
streptococcal infection is considered to specificaly trigger pediatric patients. 
It is wel established that stressful life events are associated with the manifestation of OCD 
(Rosso et al., 2012). Although intuitively sound, a systematic assessment of traumatic events was 
only developed relatively lately.  Specificaly, new tools such as  Paykel’s  Recent  Life  Events 
Interview, have enabled studying the link between trauma and OCD in a more systematic manner 
(McKeon et al.,  1984).  Using this assessment tool, it  was shown that  6  months  prior to  onset, 
patients  often experienced a  higher frequency  of important life events,  with a  peak at  1  month 
before  OCD  onset (McKeon et al.,  1984).  Moreover,  many  patients are  diagnosed  with  OCD 
along with post-traumatic stress disorder (Dinn et al., 1999; Fontenele et al., 2011). The causality 
of this link  was indicated  by the rise in  new  OCD cases after road-trafic accidents, sexual 
assaults, combat exposures and personal violence (de Silva and Marks, 1999), but see (Grabe et 
al.,  2008).   However,  no mechanism  of  how life trauma might trigger  OCD has curently  been 
proposed. 
The second environmental factor  proposed to trigger  OCD is an immune response after 
streptococcal infection. In the  1990’s,  Dr.  Swedo from the National Institutes  of  Mental  Health 
observed  50  pediatric  patients who displayed a rapid  onset of OCD after a Group-A  Beta-
Hemolytic Streptococcal infections (GABHS) induced by Streptococcus pyogenes (Swedo et al., 
1998). The authors coined the term Pediatric Autoimmune Neuropsychiatric Disorders Associated 
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with  Streptococcal infections (PANDAS) for this subgroup  of  patients.  Although stil  not an 
oficial  diagnosis in  many countries,  OCD triggered  by streptococcal infection is finaly being 
recognized. In fact,  PANDAS are etiologicaly and symptomaticaly related to  wel-known 
Sydenham chorea.  Apart from the iconic  motor  manifestations  of  St.  Vitus  dance,  neurological 
symptoms of  Sydenham chorea include  many  OCD-like  behaviors (Pérez-Vigil et al.,  2016). 
Moreover, the presumed trigger of both disorders is an abnormal immune reaction folowing these 
infections.  Anti-neuronal autoantibodies in both Sydenham chorea and  PANDAS react  with 
antigens  present  on  dopamine receptors (Brimberg et al.,  2012;  Cox et al.,  2013). Importantly, 
Streptococcus  pyogenes  have  been specificaly shown to  produce antibodies that react  with 
dopamine  D2 receptors in laboratory rats (Brimberg et al.,  2012;  Cox et al.,  2013).  Moreover, 
there is a  direct relationship  between the level  of anti-streptococcal antibodies and symptom 
intensity in OCD (Murphy et al., 2015). 
To sum  up, evidence supports the idea that environmental factors (life traumas and 
infection)  have a significant influence on the  development  of OCD.  However, susceptibility to 
environmental triggers, especialy traumas, is potentiated by the genetic makeup of an individual. 
 
3.5.2 Genetic factors 
There is consensus that OCD is, at least partialy, geneticaly determined. The higher prevalence 
of  OCD among relatives  of already  diagnosed  OCD  patients (do  Rosario-Campos et al.,  2005; 
Grabe et al.,  2006) and twin studies (van  Grootheest et al.,  2005) suggest that there is a strong 
genetic component to OCD. Moreover, research indicates that the heritable component appears to 
be larger in  pediatric  patients (45-65%) compared to  patients  with adult  onset (25-47%; in  van 
Grootheest et al., 2005; Nestadt et al., 2010). Numerous atempts have been made to decipher the 
genetic  basis  of this  disorder. The  most frequent targets  of these studies include  genes for 
receptors, transporters and enzymes involved in the serotonin, dopamine and glutamate systems. 
Dopamine related  genes are described  next, as stereotypes triggered  by alterations in the 
dopamine system are the focus of this thesis. 
 
3.5.2.1 Dopamine-related genes 
Dopamine-related genes have been one focus of searches for the genetic underpinnings of OCD. 
Dopamine  dysfunction has  been implicated in OCD  pathogenesis for a long time, triggered by 
observations such as the induction of stereotypical behaviors by dopaminergic agonists (Ridley, 
1994), the effectiveness of antipsychotic augmentation to SSRI treatment (Holander et al., 2003), 
and the altered binding of D2 receptors in the striatum of OCD patients (Denys et al., 2004b). As 
mentioned above, antibodies against D2 receptors trigger  OCD  behavior in PANDAS  patients. 
Moreover, dopamine constitutes the main neuromodulator regulating the cortico-striato-thalamo-
cortical circuits – a set of interconnected brain regions that are consistently implicated in the OCD 
pathology (Koo et al., 2010). From the standpoint of genetics, OCD has repeatedly been found to 
be related to a polymorphism of dopamine receptor 4 (Milet et al., 2003; Reshma et al., 2013). 
Moreover, genes involved in the degradation of dopamine have also been associated with OCD. 
Specificaly, a monoamine  oxidase  A  polymorphism was associated  with female  OCD  patients 
with  depression (Camarena et al.,  2001;  Hemmings et al.,  2003) and low catechol-o-
methyltransferase (COMT) activity was associated with OCD in males (Karayiorgou et al., 1997; 
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Gothelf et al., 2004). Associations between a COMT polymorphism in males and MAO-A  with 
OCD  was confirmed  by  meta-analyses (Taylor,  2013;  Melo-Felippe et al.,  2016).  However, 
studies that did  not separate  male and female  participants failed to find an association  between 
COMT and  OCD, ilustrating the dificulties involved in drawing  general conclusions about the 
hypothetical, al-encompassing population of ‘OCD patients’ (Erdal et al., 2003; Sampaio et al., 
2015). 
 
3.6 Neuroanatomy of OCD 
Although the underlying ‘causes’  of  OCD are  unknown, the OCD etiology converges to a 
common defect in the functioning of cortico-striato-thalamo-cortical (CSTC) circuits (Milad and 
Rauch, 2012). Al CSTC circuits have a common scheme of projection – they link cortical regions 
with striatum, thalamus and  back  with cortex (Figure  1). CSTC circuits are crucial for action 
selection, where actions are initiated in the cortex and are selected by the striatum (Redgrave et 
al.,  1999;  Mink,  2018).  Perhaps  more importantly,  CSTC circuits are essential in action 
suppression.  After selecting an action, a multitude of competing actions must be suppressed to 







Figure  1 |  A simplified  CSTC circuit. The cortex sends excitatory signals to the 
striatum, which inhibits external and internal segments of the globulus palidus and 
the substantia  nigra reticulata (GPe,  GPi,  SNr, respectively).  The substantia  nigra 
compacta (SNc) and  ventral tegmental area (VTA)  modulate striatal activity  by 
tonic and phasic  dopamine release.  GPe activates the subthalamic  nucleus (STN), 
which in turn inhibits the thalamus,  while GPi/SNr activates the thalamus. The 




3.6.1 Dopamine as an orchestrator of CSTC circuits 
One putative modulator of CSTC circuits is dopamine, which is thought to play an essential role 
in reward  processing and action selection – halmark functions atributed to  CSTC circuits 
(Graybiel,  2008).  The  ventral tegmental area (VTA) and substantia  nigra  pars reticulata (SNr) 
supply  dopamine to the CSTC circuitry (Albanese et al.,  1986).  Dopamine release is increased 
folowing the appearance  of  unexpected rewards  or folowing cues  predicting those rewards 
(Schultz, 2016). Otherwise, dopamine is released tonicaly and regulates overal responsiveness to 
reward-related dopamine release (Grace, 1991). In general, feedback regulates dopamine release 
by activating dopamine (D2) autoreceptors present on the VTA and SNc neurons. Activation of 
D2 autoreceptors  decreases membrane  potential  by activating  Ki inward rectifying channels 
(Beaulieu and  Gainetdinov,  2011).  Although  dopamine  modulates the activity  of al structures 
within CTCS circuits, its role in the modulation of activity in the striatum is the most prominent 
and also the most studied. 
 
3.6.2 Five paralel CSTC circuits 
Dopamine input is integrated with information originating in cortical regions and in the striatum 
(Goto and  Grace,  2008). The striatum consists  of the  nucleus accumbens, caudate and  putamen 
(Parent and  Hazrati,  1995a).  Diferent cortical areas  project to the  nucleus accumbens, caudate 
and  putamen, and are essential for  diferent forms  of action selection.  Namely, the  putamen 
receives inputs from the premotor, motor and supplementary motor area; the ventromedial caudate 
nucleus receives inputs from the orbitofrontal cortex; the dorsolateral caudate receives input from 
the dorsolateral  prefrontal cortex; while the nucleus accumbens receives input from the  dorsal 
anterior cingulate cortex (ACC) (Alexander et al.,  1986) as shown in Figure  2; adapted from 

















Figure  2 | Ilustrates specific  CSTC circuits  and subregions  of the cortex  and 
striatum involved. The motor CSTC circuit is utilized by the supplementary motor 
area (SMA) and sends aferents to the  putamen. The  oculomotor  CSTC circuit is 
utilized  by the frontal eye field (FEF) and sends aferents to the caudate  nucleus. 
The dorsolateral CSTC is utilized by the dorsolateral prefrontal cortex (DLPFC) and 
sends aferents to the caudate nucleus. The orbitofrontal CSTC circuit is utilized by 
the  orbitofrontal cortex (OFC) and sends aferents to the caudate  nucleus.  Lastly, 
the limbic CSTC circuit is utilized by the anterior cingulate cortex (ACC) and sends 
aferents to the  nucleus accumbens (NAcc).  Al  CSTC circuits  project to 
topographical segregated regions  of the internal segment  of the globulus  palidus 
(GPi)  or substantia  nigra reticulata (SNr) and then to topographically segregated 
regions of the thalamus. 
 
 
3.6.3 Medium Spiny Neurons (MSNs) of the striatum 
MSNs are the most common type of neurons in the striatum (Matamales et al., 2009). There are 
of two kinds, based on the expression of D1 or D2 receptors (D1R and D2R, respectively). Striatal 
D1 receptors increase the activity of adenylylcyclase, which usualy depolarizes neurons. Striatal 
D2 receptors,  on the other  hand, decrease adenylylcyclase activity in MSNs and lead to the 
hyperopolarization of neurons (Stoof and Kebabian, 1981). D1 and D2 receptors are expressed on 
non-overlapping, pseudo-randomly distributed populations of striatal MSNs (Keeler et al., 2014). 
Within each CSTC circuit, striatal MSNs constitute the beginnings of two paralel striato-thalamic 
pathways (Figure  3).  D1R expressing  MSNs are the beginning  of the ‘direct’ striato-thalamic 
pathway, and D2R expressing MSNs are the beginning of the ‘indirect’ striato-thalamic pathway 









Figure 3 | Ilustrates  diferneces  between the ‘direct’  and ‘indirect’ striato-
thalamic  pathways. These pathways are segregated at the level  of the striatum, 
where the ‘direct’  pathway commences  by activation  of the dopamine  1 (D1) 
receptor expressing medium spiny neurons (MSNs), and the ‘indirect’ by activation 
of the dopamine 2 (D2) receptor expressing MSNs. The indirect pathway proceeds 
by increasing activation  of the external segment  of the globulus  palidus (GPe), 
which in turn increases activation  of the subthalamic  nucleus (STN). The STN 
increases inhibition  of the thalamus by increasing the inhibitory action  of the 
globulus palidus (GPi) or the substantia nigra reticulata (SNr). The direct pathway 
produces the opposite effect  by activating the thalamus via increased activation of 
the GPi/SNr.  Balance  between the direct and indirect  pathways results in the 
initiation of desired actions (direct) and suppression of unwanted actions (indirect). 
 
3.6.3.1 Direct pathway 
D1R-expressing  MSNs  project  GABAergic inhibitory aferents to the internal segment  of the 
globus  palidus and substantia  nigra  pars reticulata (GPi/SNr), constituting the direct  pathway. 
Next, the GPi/SNr exerts tonic inhibitory activity on the thalamus (Alexander et al., 1986). When 
this  direct  pathway is activated, via  D1R-expressing  MSNs, inhibition  of the thalamus is lifted. 
Increased activity  of the thalamus in turn activates the cerebral cortex through  direct 
glutamatergic  projections (Goldberg et al.,  2013).  D1 receptors  have relatively low affinity to 
dopamine, therefore the direct pathway is activated in situations when dopamine levels are high 
(phasic  dopamine release) and  promotes the execution of selected  motor/cognitive  programs 





3.6.3.2 Indirect pathway 
On the  other  hand, the indirect  pathway was long considered to  be constitutively inhibited  by 
baseline dopamine levels maintained by the tonic release of dopamine, due to the higher afinity 
of inhibitory D2 receptors to dopamine (Dreyer et al., 2010; Surmeier et al., 2011). However, this 
notion was recently chalenged, as it was shown that D2 receptors, which are most often in low 
afinity state, also respond to phasic dopamine release despite being activated by tonic dopamine 
release (Marcot et al., 2014). This information has not yet been incorporated into the theoretical 
framework  of  basal  ganglia function. In curent  models, the indirect pathway is essential in the 
inhibition of unwanted motor/cognitive programs via inhibiting the thalamus. 
D2R-expressing  MSNs  project to the external segment  of the globus  palidus (GPe) 
(Calabresi et al., 2014). When dopamine levels increase, D2R-expressing MSNs are inhibited and 
disinhibit target  neurons in the GPe.  Disinhibited  GPe  neurons send inhibitory signals to 
coresponding STN neurons and also to coresponding neurons in the GPi/SNr (Calabresi et al., 
2014). The STN sends glutamatergic aferents to al basal ganglia structures, including the GPe 
and GPi/SNr (Koshimizu et al., 2013). In fact, STN connections to the GPe are more numerous 
than connections to the GPi/SNr (Sato et al., 2000; Koshimizu et al., 2013). Increased excitability 
of  GPi/SNr  neurons  by the STN  potentiates its inhibitory efect  on the thalamus.  However, the 
STN also sends  glutamatergic  back-projection to the GPe, which increases the GABAergic 
inhibitory tone of the GPe on the GPi/SNr (Chu et al., 2015). 
 
3.6.3.3 Models of action selection by CSTC circuits 
At present, there are two models that describe action selection by CSTCs – the ‘Go/No-Go’ model 
and the ‘prepare and select’ model. 
The traditional model  of  CSTC  proposes that  when the direct  pathway  overides the 
activity of the indirect pathway, tonic inhibition of the GPi/SNr (by the indirect pathway) on the 
thalamus is decreased and motor/cognitive programs are facilitated (Frank, 2005). This theory is 
exemplified by the Go/No-Go model (Frank, 2005). Only in situations when dopamine levels are 
low, such as in cases of absent expected rewards, D2 expressing neurons of the indirect pathway 
become active and inhibit the GPe, with a subsequent increase of inhibition of the thalamus and 
suppression of motor/cognitive programs (Parent and Hazrati, 1995b). Activation of the indirect 
pathway  was speculated to facilitate a broader  behavioral repertoire that aids in finding  novel 
rewarded behaviors (Humphries et al., 2012). 
The newer ‘prepare and select’ (PAS) model of basal ganglia proposes that the indirect pathway 
does  not inhibit action,  but in fact  promotes it,  because  previously activated  D2R-expressing 
MSNs are D2R free due to D2R internalization. The function of the direct pathway in this model is 
to  ofer a range  of  possible  behaviors, and the function  of the indirect  pathway is to select the 









3.6.4 CSTC circuits in OCD 
It has  been suggested that in  OCD the direct  pathway is hyperactive compared to indirect 
pathway, resulting in the absence  of a ‘stop signal’ folowing successful execution of a 
cognitive/motor program (Pauls et al., 2014; Karas et al., 2019). Figure 4 ilustrates the disbalance 







Figure 4 | In  a  normaly functioning  CSTC circuit (panel  A),  direct (D1R 
expressing) and indirect (D2R expressing)  pathways increase or  decrease 
inhibition  of the thalamus (GPi/SNr), respectively, in a  balanced  way. In  OCD 
(panel  B),  hyperactivation  of the  direct  pathway non-proportionally to the indirect 
pathway induces a pathologic  hyperactivity  of cortical regions resulting in an 
excitatory loop. Blue arows signify glutamatergic transmission. Red arows signify 
GABAergic transmission. Abbreviations:  GPe – external segment  of the globus 
palidus; GPi – internal segment of the globus palidus; SNr – substantia nigra pars 
reticulata; STN – subthalamic nucleus; NAcc – nucleus accumbens; ACC – anterior 
cingulate cortex; OFC – orbitofrontal cortex. 
Although  CSTC circuits are traditionaly  described as separate, there is a functional and 
anatomical  overlap  between them (Haber,  2016).  Nonetheless, in the context of  OCD it is 
advantageous to  describe the circuits separately, with each circuit  named after the cortical area 
that it ‘supplies’ (orbitofrontal, anterior cingulate, dorsolateral prefrontal, motor, and oculomotor). 
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Of these circuits, the  orbitofrontal (OFC) and anterior cingulate (ACC) cortices are involved in 
the pathology of OCD (Maia et al., 2008; Piras et al., 2013). These cortices have been shown to 
contribute to ritual formation and eror detection, respectively (Holerman et al., 2000; Van Veen 
and  Carter,  2002).  As  mentioned above, ‘coresponding’  dorsal and  ventral striatal regions are 
caudate for the OFC and the nucleus accumbens for ACC (Provost et al., 2015). 
Findings in  OCD  patients suggest that the cortical structures implied to  be abnormal in 
OCD are the orbitofrontal and anterior cingulate cortices (Maia et al., 2008; Bokor and Anderson, 
2014).  Moreover, subcortical abnormalities  have also  been consistently found in the caudate 
nucleus  of the striatum (Calabrese et al.,  1993;  Hansen et al.,  2002;  Menzies et al.,  2008). 
Importantly, alterations  within the temporal lobe structures, such as the  hippocampus and 
amygdala, are also present in OCD patients (Atmaca, 2011; Ulman and Pulman, 2015). 
Observed abnormalities in the above-mentioned structures include structural changes, changes in 
volume, changes in  white  mater  density and altered  metabolism at rest,  during symptom 
provocation, and also in cognitive tasks. Since the present thesis focuses  on the activity  of the 
hippocampus in an animal  model  of  OCD and  on cognitive flexibility,  only alterations in the 
hippocampal region in OCD wil be described. 
 
3.6.5 The hippocampus in OCD 
There are several brain regions that are recurently implicated in OCD. These include regions that 
are  part  of the aforementioned  CSTC loops,  namely the lateral  orbitofrontal cortex, anterior 
cingulate cortex, and caudate nucleus. However other structures that are not part of CSTC loops 
are also involved in OCD. These include the hippocampus and amygdala. The hippocampus is a 
wel-studied brain region implicated in memory formation, consolidation, retrieval and in spatial 
orientation (Moscovitch et al.,  2016). Importantly, animals  with lesions  of the hippocampus 
display stereotypical  behavior such as a decrease  of spontaneous alternation  behavior (Lalonde, 
2002). 
Supporting its role in stereotypical  behaviors,  hippocampal aberations have repeatedly 
been observed in OCD. Reduced hippocampal volume has  been observed in patients with OCD 
(Kwon,  2003;  Atmaca et al., 2008).  Additionaly,  OCD  patients have exhibited increased 
activation in the left  posterior  hippocampus compared to control subjects  during reward  based 
learning (Marsh et al.,  2015) and  greater activation  of the right  hippocampus  during implicit 
sequence learning (Rauch et al.,  2001,  2007).  Moreover, activity  of the right  hippocampus is 
increased after symptom  provocation (Adler et al.,  2000) and hippocampal  hyperactivity 
decreased after successful SSRI treatment (Kang et al., 2003). 
However, medial temporal lobe structures do not fit within the established theoretical framework 
of OCD etiology. One theory that considers the hippocampus in OCD pathology gives it a role in 
compensating for deficiencies in procedural memory in OCD (Ulman and Pulman, 2015). 
Many brain regions implicated in OCD are important in cognitive flexibility, reward-based 
decision-making, response inhibition and task switching (Pauls et al., 2014). Therefore, it is worth 
asking if OCD patients are also impaired in tasks that test these abilities. Since OCD behavior is 
often  described as  very inflexible, it is  not surprising that flexibility has  become a cognitive 
domain that has received much atention. The next chapter wil describe how diferent forms of 
cognitive flexibility are compromised in OCD patients. 
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3.7 Cognitive flexibility in OCD 
Cognitive flexibility is the ability to change a  behavior in response to a changing environment 
(Dajani and Uddin, 2015). Adaptation to new situations is quintessential to the survival of almost 
every species  on  Earth.  However, inflexible or rigid behavior can also  be adaptive.  When 
conditions are stable, the formation  of automatic  behavioral  paterns (rituals) decreases the 
cognitive load for many otherwise mundane tasks. OCD itself is marked by very inflexible, rigid 
behavior (both obsessions and compulsions rarely change). In fact, OCD has been considered to 
be an exaggeration of the natural tendency to form adaptive habits (Gilan et al., 2011). 
As  hinted above,  many  of the  brain regions implicated in  pathology  of  OCD are also 
implicated in cognitive flexibility.  These  brain regions include the  orbitofrontal cortex 
(Schoenbaum et al.,  2007), anterior cingulate cortex (Ragozzino and  Rozman,  2007), amygdala 
(Schoenbaum et al., 2003) and hippocampus (Rubin et al., 2014). Not surprisingly then, cognitive 
flexibility has become an intensively studied characteristic of OCD (Gilan et al., 2011). Although 
an impairment of cognitive flexibility is curently considered to be integral part of OCD, it is not 
true that al forms of cognitive flexibility are compromised in OCD. The  next section  discusses 
the three most common types of cognitive flexibility – as tested in experimental environments – 
and how they relate to OCD. 
 
3.7.1 Atentional Set Shifting 
Atentional set shifting tests the capability of switching atention from one aspect of a stimulus to 
another without receiving a cue regarding contingency changes. However, feedback is available if 
the selection  was ‘corect’  or ‘wrong’.  Only changes in feedback can  be  used to  determine 
changes in contingencies.  Set shifting is an essential aspect  of cognitive flexibility (Dajani and 
Uddin,  2015) and it is commonly tested by Intra-dimensional/Extra-dimensional shift tasks. In 
these tasks,  patients are  usualy  presented  with cards representing  objects  with two  diferent 
dimensions – atributes such as color and shape. The patient determines a rule (which color/shape 
is rewarded) and applies the rule until the feedback changes. After a feedback change patients are 
chalenged to determine a new rule and folow it. Intra-dimensional set shifting occurs within a 
dimension  – when a red color, for example,  was a rewarded atribute and it changes to a blue 
color.  Extra-dimensional set shifting,  on the  other  hand, is tested  when the change  of the rule 
happen  outside  of the  dimension – for example  when the red color,  which  was  previously the 
rewarded atribute, stops being rewarded in favor of, for example, square shaped objects. 
In OCD patients, some studies have reported reduced performance in extra-dimensional set shifts 
(Veale et al., 1996; Watkins et al., 2005; Chamberlain, 2007), while others have reported deficits 
in intra-dimensional set shifts (Veale et al.,  1996;  Fenger et al.,  2005).  Overal,  deficits in set 
shifting in  OCD  patients  present as an increase in  perseverative erors – patients  more  often 
folow an  old rule  despite a change in fedback (Shin et al.,  2014;  Snyder et al.,  2015). 







3.7.2 Reversal learning 
Reversal learning is considered to  be the simplest test  of cognitive flexibility. Generaly, it is 
similar to intra-dimensional shifting, but there are only two options to choose from. Subjects are 
reinforced to respond to  one choice/spatial location  until a criterion is reached.  Next, 
reinforcement changes to another choice/spatial location (Izquierdo et al., 2017). Damage to the 
OFC specificaly is associated  with impaired reversal learning (Dias et al.,  1996;  Hornak et al., 
2004; Boulougouris et al., 2007), therefore, the performance of OCD patients in reversal learning 
has been of great interest.  
Researchers have often observed no behavioral deficiencies in reversal learning in OCD patients; 
however, they have often observed changes in the recruitment of brain regions within CTSC loops 
during such tasks (Chamberlain et al.,  2008). Remijnse and coleagues (Remijnse et al.,  2006a) 
showed a reduced responsiveness of the OFC and the caudate during rewarded switching reversal 
tasks in  OCD  patients.  Another study reported a lower lateral activity in the OFC and lateral 
prefrontal cortex in patients with OCD during a reversal task (Menzies et al., 2008). Behavioraly, 
however, apart from a slower response, no performance deficiencies during the task were detected 
(Valerius et al., 2008; Ersche et al., 2011). The observed slowness may suggest that OCD patients 
require  more  processing time  when chalenged  with altered response-reward contingencies and 
have an altered processing of cognitive information during reversal learning. 
 
3.7.3 Task switching 
Task switching is represented by cued switching tasks (Korte et al., 2002). During the task, the 
subject has to work on two paralel tasks that alternate. Rules of the task are explicitly stated and 
erors are marked. Immediate feedback is also provided when errors are made. 
OCD patients showed increased eror rates and lower activation of the OFC, ACC, and caudate 
nucleus during cued task switching compared to control subjects (Gu et al., 2007). Reminjse and 
coleagues also found hypoactivation of the OFC in OCD patients during a similar switching task 
(Remijnse et al.,  2013).  However, in contrast to the previous study, these authors found 
hyperactivation of the ACC. Although Remijnse and coleagues observed slower reaction times, 
the eror rate was lower in OCD patients compared to controls. Similarly, Vriend and coleagues 
found a  more accurate,  but slower,  performance  of  OCD  patients  on a similar switching task 
(Vriend et al.,  2013).  These results  were explained as a strategic tradeof for the sake  of  not 
making mistakes in OCD patients. 
Cognitive flexibility, when measured in experimental setings, is generaly not impaired in 
OCD  patients; however,  general slowness and abnormalities in  brain activations has often been 
observed. Slowness of responses in OCD possibly indicates a higher cognitive load. It is therefore 
possible that a  more  difficult task  would reveal a  behavioral  deficit. Moreover,  when tested, a 
similar alteration in  brain circuitry was also  observed in  unafected relatives of  OCD  patients 
(Chamberlain,  2007;  Menzies et al.,  2008;  Rajender et al.,  2011). Therefore, abnormal 
neurophysiological  processing  during tasks requiring cognitive flexibility could  be an 
endophenotype of OCD (Gruner and Pitenger, 2017). Importantly, cognitive flexibility is much 




3.8 Studying neuronal substrates of OCD using animals models  
Many brain regions are implicated in OCD, yet where and how stereotypical behavior is generated 
is stil  unknown.  Causal relationships can  mostly  only  be  deciphered through intentional 
manipulation of an atribute that is being tested as causative. Of course, such manipulations are 
unethical to perform in humans, so animal models must be used. Apart from the possibility to test 
causal relationships, animal models alow the use of much more invasive methods to probe brain 
function. 
Exploring  brain activity  using high-resolution  molecular imaging  using in situ fluorescence 
hybridization (FISH)  of immediate early  gene (IEG)  mRNA is of  great  help in this regard. It 
alows the exploration  of brain activity at single cel resolution during any selected  behavior in 
many  brain regions at  once (Kubik et al.,  2007).  This method is similar to  magnetic resonance 
imaging in the sense that it alows the visualization of brain activity in many brain areas.  
Changes in the expression of genes related to neuronal activity  – IEGs – can be used to 
map preceding neuronal activity (Okuno, 2011). Upregulation of the expression of these genes is 
triggered  by the activation  of cAMP-response element  binding  proteins (CREB)  preceded  by a 
Ca2 influx into the neuron (Mermelstein et al., 2000; Vazdarjanova et al., 2006). Because of this 
expression, IEGs, such as Arc and cFos are used as markers of neuronal plasticity (Minatohara et 
al.,  2015). Arc (activity‐regulated cytoskeletal associated  protein,  or  Arg  3.1) mRNA can  be 
detected in the nucleus in a very short time window – 2-5 minutes folowing neuronal activation 
(Kubik et al.,  2007).  For this reason, high-resolution  molecular imaging of Arc mRNA is 
advantageous for detecting neuronal correlates  of  discrete bouts of behavioral activity. Methods 
such as this  ofer unique information about  neuronal activity accompanying  behavior in animal 
models. 
 
3.8.1 The quinpirole sensitization model of OCD 
Although there are numerous models of obsessive-compulsive disorder, few of them possess such 
striking similarity to  OCD  behavior as the quinpirole-sensitized  model (QSM).  Rats sensitized 
with the dopamine  D2/D3 receptor agonist  quinpirole (QNP)  produce checking  behavior  very 
similar to  OCD  patients.  Because  of this, and  because this  model is the  one within  which 
experiments in this work were conducted, it is the only OCD animal model described here. 
The best way to describe an animal model is by its validity – how wel it models a certain 
disease. Validity can be subdivided into three components – face validity, construct validity and 
predictive  validity (Wilner,  1986).  Face  validity coresponds to the similarity in  disease 
manifestation. In  models  of  psychiatric disorders, face  validity is  mainly concerned  with 
similarities in behavior. Construct validity is present when the same physiological substrates are 
afected in the disease and the animal model. These include similar alterations in neurotransmiter 
systems,  brain structures and  morphology (Albelda and Joel,  2012).  Last,  predictive  validity is 
most important if an animal  model is to  be  useful in aiding the finding  of novel treatments. It 
coresponds to the efectiveness of the same treatments in both the disease and the animal model. 
No animal model is valid in al aspects.  However, depending on the aim  of the study, a certain 
type  of  validity may be preferred  over the  others. In this  work,  where  we aim to  decipher 
neurophysiological corelates of stereotypical checking, face validity is the most important aspect 




3.8.1.1 QSM face validity 
Repeated administration of quinpirole induces several stereotypical behaviors, suggesting a high 
face  validity  of this  model (Stuchlik et al.,  2016).  When repeatedly introduced into an object-
enriched open-field arena, quinpirole-sensitized animals display substantial stereotypy of behavior 
compared to controls.  Namely, these animals  make many more returns to  one  or two selected 
objects in the open-field (Szechtman et al., 2001). 
Similarly,  OCD  patients are frequently involved in a selected few repetitive  behaviors – 
compulsions – aimed to relieve obsessive recurent thoughts (Stein et al., 2016). To appreciate the 
similarity  between  quinpirole sensitized animals and  OCD, Szechtman and coleagues asked 
readers to view human behavior in ethological terms (Szechtman et al., 1998). They proposed five 
criteria to assess checking behavior in both rodents and humans: 
 
1. There are one or two prefered location/objects of visiting. 
2. The animal/patient returns to this location/object more often.  
3. The animal/patient  visits fewer other location/objects  prior to the return to the favorite 
location/object. 
4. The animal/patient  preforms a characteristic set  of acts  when  visiting these 
locations/objects. 
5. The animal/patient behavior changes when the environment is changed. 
 
Al these criteria are  met  by  both  OCD  patients and QNP sensitized rats (Szechtman et al., 
2001). Apart from the striking similarity to patients in checking behaviors, the QNP sensitization 
model of OCD also displays a deficit in cognitive/behavioral flexibility, a halmark of OCD – as 
was discussed in the previous chapter. 
 
3.8.1.2 Cognitive inflexibility in QSM 
Specificaly, QNP sensitized animals show reduced spontaneous alteration (Einat and Szechtman, 
1995).  As already  mentioned, spontaneous alteration  utilizes the natural tendency  of animals to 
explore  new environments (Deacon and  Rawlins,  2006). In an experimental setup in a T-maze, 
flexibility is manifested as choosing the opposite arm to an arm visited on a previous trial when 
given a free choice. Cognitive inflexibility is also manifested by a deficit in a paradigm known as 
contrafreeloading.  QSM animals choose to  work for a resource, instead  of  obtaining it for free 
(Amato et al., 2008; De Carolis et al., 2011). In short, water deprived animals are first trained to 
obtain a drop of water by pressing a lever. Next, animals are ofered a choice between pressing a 
lever and drinking water that is freely available (Jensen, 1963). Despite the benefits of free water 
access, QSM animals continue to press the lever to receive water. Continuous pressing in QSM 
animals is unrelated to their thirst, as these animals do not drink al the water they were ofered 
and even drink less than control animals (De Carolis et al., 2011; Schepisi et al., 2014). Moreover, 
cognitive flexibility insuficiency in  QSM  was  observed as a  deficit in a two-lever spatial 
discrimination reversal learning task (Boulougouris et al.,  2009).  Clearly,  mounting evidence 
indicates that sensitization by QNP produces two halmark characteristics of OCD – stereotypical 
atendance to locations and objects, and cognitive inflexibility. 
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3.8.1.3 QSM construct validity 
Compared to face  validity, the construct  validity  of  QSM is somewhat less convincing. In this 
model we consider the involvement of same neurotransmiter systems (dopamine) and same brain 
regions (CSTC structures) as support for construct validity. 
The  decrease  of  D2/D3 receptor  binding  using [11C]raclopride in  QSM supports the construct 
validity  of this  model.  Raclopride is a  derivate  of a selective antagonist  of  D2 receptors.  By 
labeling raclopride with the radioactive isotope 11C, it is possible to visualize the density of D2 
receptors (Ikoma et al.,  2010).  A  decrease  of  D2/D3 occupancy in striatum has  been shown in 
both OCD patients (Denys et al., 2004b) and in QNP sensitized animals (Servaes et al., 2017); but 
see (Culver et al., 2008). 
As aforementioned, the  brain regions that are repeatedly found to  display alterations in 
OCD are the orbitofrontal cortex, anterior cingulate cortex, and caudate  nucleus. In  QSM, it 
appears that similar structures are involved, although in some cases in an opposite manner as is 
implicated in OCD. 
Several studies have explored the activity of numerous brain regions after repeated QNP 
treatment.  Most of these studies used local cerebral glucose utilization (LCGU) by quantitative 
radiography to  visualize the metabolism  of cortical structures after sensitization to  QNP.  These 
studies confirmed the involvement  of  CSTC structures in  QSM; however, instead  of elevated 
glucose  utilization, as  would  be expected in a constructively  valid  OCD  model, decreased 
utilization of glucose was observed. Carpenter and coleagues (Carpenter et al., 2003) observed a 
14% decrease  of  LCGU in the caudate/putamen  of  QNP sensitized animals.  This study also 
confirmed a decrease of activity in the nucleus accumbens. Another study that focused on anterior 
cortical areas showed an  overal  decrease  of cortical activity (Richards et al.,  2005).  Glucose 
utilization was reduced in the anterior cingulate cortex (by 19%), lateral orbitofrontal cortex (by 
18%) and in the medial and  ventral  orbitofrontal cortices (by  17%).  Another study  using 
multichannel electrophysiological recordings showed that  QNP  dose-dependently  decreased the 
activity  of the anterior cingulate cortex and striatum in the first  15  minutes after  quinpirole 
application (Huang et al., 2013). Another study utilizing [18F]-FDG PET  neuroimaging did not 
replicate the  decreased cortical activity in  quinpirole sensitized animals,  but found a significant 
reduction of cerebral glucose utilization in the hippocampus (Servaes et al., 2016). 
Possibly, as some authors suggest, it is  possible to consider the QSM model as  valid 
merely on the grounds of involvement of the ACC, OFC and striatal regions. Although a single 
study found over-activation of the ACC and striatum in later stages  of  QNP sensitization,  most 
studies present a diferent  picture – that the opposite  directions  of  metabolic changes in OCD 
patients and the QNP model are very consistent, and that reconciliation is hardly possible. 
 
3.8.1.4 QSM predictive validity 
The  predictive  validity  of  QSM has  not  yet  been explored in any great  detail.  However, the 
efectiveness  of clomipramine,  DBS  of the nucleus accumbens and  high frequency stimulation 
(HFS) of subthalamic  nucleus supports QSM as a  good  predictive  model  of  OCD. Namely, 
clomipramine  was shown to  postpone the  development  of checking  behavior (Szechtman et al., 
1998) and also to atenuate contrafreeloading (De  Carolis et al.,  2011). Importantly, 
antipsychotics alone were not capable of atenuating contrafreeloading (De Carolis et al., 2011). 
26 
 
On the  other hand, fluoxetine, an SSRI  used to aleviate  OCD symptoms and to  validate  other 
animal models of  OCD,  did not ameliorate stereotypic  behavior (Colu et al., 1997).   However, 
DBS of the nucleus accumbens shel and core reduced checking symptoms (Mundt et al., 2009). 
DBS  of the nucleus accumbens is a successful treatment method for OCD (Islam et al.,  2014). 
Moreover, a successful reduction of quinpirole-induced checking was also observed after HFS of 




3.9 Knowledge Gaps  
As is clear from the text above,  OCD is a relatively poorly understood multifaceted psychiatric 
disorder. Moreover, treatment of OCD is complicated. To treat OCD more efectively, preclinical 
research using valid animal models is necessary. We described a popular animal model of OCD – 
stereotypical checking folowing sensitization with D2R agonist quinpirole. Though to the best of 
our  knowledge  dopamine levels  or its  metabolites have not  yet been assessed in  OCD  patients, 
indirect evidence suggests the involvement  of the dopamine system in  OCD.  Childhood  OCD 
triggered  by streptococcal infection is characterized  by the production  of antibodies against  D2 
striatal receptors (Brimberg et al., 2012; Cox et al., 2013). Moreover, reduced D2R binding was 
found in the left caudate  nucleus  of  OCD  patients  using [11C]raclopride  binding (Denys et al., 
2004a).  Also,  both enhanced and reduced  dopamine transporter  density has  been observed in 
OCD patients (van der Wee et al., 2004; Kim et al., 2007). Involvement of dopamine in OCD is 
also indicated  by the efficiency  of antipsychotic augmentation  of  SSRI treatment (Koo et al., 
2010). The involvement  of  dopamine in  OCD is therefore  very likely in light  of curent 
knowledge. In this context, the QNP induced model  of OCD is  very  promising.  Since the 
hippocampus is  often implicated in  OCD  but  does  not receive  much atention by the scientific 
community, the focus  of this  work is  on the activity  of the hippocampus  during  QNP-induced 
stereotypical checking. Similarly, although a cognitive flexibility deficit in OCD is implicated, not 
many studies have addressed cognitive flexibility in QNP sensitized animals. This work assessed 
cognitive flexibility in QNP treated animals using a hippocampus-dependent Carousel maze task 










AIM  1: To characterize checking  behavior in quinpirole sensitized rats 
in an enriched open-field arena, as described by Szechtman (1998). 
 
AIM  2: To  determine if checking in quinpirole sensitized rats is 
associated  with changes in the expression  of the immediate-early  gene 
Arc in the hippocampal CA1 area. 
 
AIM  3: To  determine if quinpirole sensitized rats  display inflexible 
behavior in a hippocampus dependent Carousel maze task. 
 
AIM  4: To  determine if clomipramine, risperidone  or a combination 
thereof ameliorates cognitive flexibility deficits in quinpirole sensitized 
rats. 
 
AIM  5: To  determine  how  quinpirole and clomipramine treatments 
afect  performance in a hippocampus independent two-way active 
avoidance in shutle boxes.  
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Adult male  Long-Evans rats from the breeding colony of the Institute of  Physiology CAS were 
used.  Al rats  weighed  300-400g at the start  of experiment and  were  12-15  weeks  of age.  Rats 
were housed 2-3 rats per cage in an air-conditioned rat room with a stable temperature of 22oC, 
constant humidity and 12/12-light/dark cycles. Al experiments were conducted in the light phase 
of the day. Food and water were freely available. Prior to the experiments rats were handled for 2-
min  daily for  3  days.  Al rat  manipulations  were conducted in accordance  with the  Animal 
Protection  Code  of the  Czech  Republic and the corresponding  directive  of the  European 
Community Council on the use of laboratory animals (2010/63/EC). 
 
5.2 Stereotypical checking in QSM 
5.2.1 Apparatus – enriched open-field arena 
The open-field arena  was  made  of  white  waterproof  plastic surrounded  by  black  plastic 
unreflective wals (arena: 95x95cm; wals: 95x50cm). Two objects were placed inside at random 
locations between the wals and the center (Figure  5). The  whole open-field arena was elevated 
1m above the floor  with a  video camera  placed above it.  During the animal testing, a trained 












5.2.2 Behavioral procedure 
The spontaneous behavior of animals in the enriched open-field was observed in ten 50min daily 
sessions folowing  quinpirole (QNP; n  =  13)  or saline (SAL; n  =  13) administration.  QNP  was 
dissolved in saline and administered subcutaneously 50min prior to behavioral testing at a dose of 
0.5mg/mL/kg. In the control group saline was administered at a volume of 1mL/kg 50min prior to 
behavioral testing.  Folowing injection, animals  were left  undisturbed for  50min in their  home 
cage. Next, each animal was placed into the most proximal corner of the enriched open-field arena 
facing a wal.  After the experimenter left the room, a 50min recording of animals’ spontaneous 
activity commenced.  
 
5.2.3 Measured parameters and statistical analysis 
Obtained recordings were analyzed using a video-tracking system monitoring the position of the 
mouse head, body and tail (Viewer2, Biobserve BmbH). The focus of analysis was on the most 
important objects of checking – two objects and al four corners of the arena – and the number of 
visits to each object/location (‘zone’) was the main output parameter of interest.  
After  obtaining the frequency  of  visits, zones were re-labeled based  on frequencies of 
visits. The  most  popular zone was labeled ‘A’; the second favorite ‘B’ and so  on. The sum  of 
visits in al 10 sessions was used to determine the preference of a zone for each animal separately 
(see  Figure  6). Thus, data from each  group (either QNP or  SAL) could be pooled and analyzed 
together. Such an analysis is an extended version of previous analyses where visits to key-locale 
were analyzed,  with the  key-locale being the most frequently  visited zone for each animal (De 




Figure 6 | Ilustration of zone labeling. Panels A and B represent visits to zones by 
two diferent animals. For each animal al visits for each zone were summed from 
al sessions (‘total # of visits’). For each rat zones were re-labeled based on the total 
number  of  visits to a  given zone (‘re-coded zones’). Label ‘A’  was given to  most 




5.3 Arc expression during checking behavior in the CA1 area of the hippocampus  
This part of experiment was conducted after animals were repeatedly exposed to the arena and a 
stable checking patern was established in QNP treated animals. 12 hours prior to the experiment 
al rats were single-housed in opaque white cages and handled very carefuly. Animals received 
either QNP or saline based on their group designation as during sensitization sessions. Next, rats 
were  placed into the enriched open-field in the same  manner as  during  previous  50min 
sensitization sessions.  This time, the session  was  only  5min long to equalize the locomotor 
activity  between  QNP treated and control rats. Five QNP sensitized rats and three control rats 
were designated as cage controls (CC  groups).  These animals  were left in the  opaque cages 
throughout the whole experiment. Folowing 5min of exploration (OF groups) or 55min folowing 
injection in  opaque cage (CC  groups), the rats  were  deeply anesthetized  with isoflurane and 
decapitated. Their brains were quickly removed, flash-frozen in a dry-ice-cooled isopentane bath 
and stored in a -80°C freezer. 
 
5.3.1 Tissue preparation 
Upon tempering to -20°C, four-milimeter segments from 6-8 animals containing the hippocampi 
of right hemispheres  were aranged in  blocks, maximizing the  number  of  within-block and 
between-group comparisons.  Blocks  were embedded in  optimal cuting temperature  medium 
(OCT;  Sakura), sectioned at  20µm in a cryostat (Leica  CM  1850,  Germany) and  mounted  on 
gelatin-coated superfrost slides (Fisher).   Later, sections were  processed for fluorescence in situ 
hybridization as  previously  described (Vazdarjanova and  Guzowski,  2004;  Kubik et al.,  2012). 
The protocol used is briefly described below. 
Hybridization  bufer,  which was also  used as a  prehybridization  bufer,  was made a day in 
advance. Hybridization bufer was prepared from formamide (50%), saline-sodium citrate (SSC) 
bufer,  RNAse-free  water,  dextran sulfate (0.05g/ml),  50X  Denhardt solution (resulting 
concentration 1X), yeast RNA (250µl/ml) and sonicated salmon sperm DNA (500µl /ml). Glass 
slides  with  brain sections  were submerged in racks into the folowing solutions (in  250ml 
containers) in the order listed: 
 
• 4% chiled paraformaldehyde solution (5min) 
• SSC bufer (4min) 
• Acetic anhydride solution (10min) – this solution was prepared by dissolving 2.3g of  NaCl, 
3.7ml of triethanolamine in 250ml of RNAse free water,  which was immediately before use 
enriched with 1.25ml of acetic anhydride. 
• RNAse free water (dip) 
• Chiled acetone/methanol mixture (1:1, 5 min) 






Tissue  preparation  was folowed  by  pre-hybridization.  120  µl  of  hybridization  bufer  was 
applied to each glass slide and cover-slipped (to ensure that liquid stayed on the glass, it was lined 
with two hydrophobic parafin lines). Glass slides were covered by a cover glass and incubated at 
room temperature for 30min. 
Meanwhile, digoxigenin-labeled Arc antisense riboprobes were prepared for hybridization. 
The  probe  was  placed into the  prepared  hybridization  bufer to achieve a concentration  of 
1ng/µm. Hybridization  bufer  with  probe  was heated to  90°C for  6 minutes to  denature the 
riboprobes.  Again,  120µl  of  hybridization  bufer  with riboprobes  was applied to sections and 
cover-slipped. Glass slides were then placed on a rack and left to incubate at 56°C for 16 hours. 
During this time, Arc antisense riboprobes hybridized with RNA fragments of Arc RNA. 
The  next  day, cover glasses  were removed  by  dipping the slides in SSC  bufer, and the 
brain sections were washed in 2X SSC bufer (0.3M NaCl and 0.03M sodium citrate) for 5 and 
10min, consecutively. Sections were then incubated with 25 µl RNAse1 (ThermoFisher scientific 
EN0602) in 250ml  SSC  bufer, 15min in  37°C) to rinse off al  un-hybridized riboprobes. 
Subsequently, glass slides were rinsed in 2X SSC bufer for 3 and 5min consecutively and then 
for  30min in warm 0.5X  SSC  bufer (75mM  NacL and  7.5mM sodium citrate; 56°C).  Next, 
endogenous  peroxidase activity  was inhibited  by saturating  brain sections  with a 3%  hydrogen 
peroxide solution (in 250ml of 2X SSC bufer for 15min). Then sections were rinsed twice in 2X 
SSC bufer for 5min. Next, glass slides were incubated for 10min in blocking bufer (TSA Perkin 
Elmer  kit  NEL404A)  produced  by  dissolving  0.1g  of  blocking  bufer  powder in  250ml of  Tris 
bufer saline (TBS)).  Anti-digoxigenin antibody (Anti-Dig-POD,  Fab fragments from sheep, 
Roche) conjugated with horseradish peroxidase (HPR) was then diluted 1:300 in blocking buffer. 
150 µl of diluted antibody was applied to each slide, cover-slipped and left to incubate for 2h at 
room temperature. Folowing incubation cover slips were washed away in TBS. Glass slides were 
then washed in TBS-T (TBS enriched with 0.5mL/L Tween20) three times for 5min. 
Next, the antibody signal was potentiated using a Tyramide Signal Amplification (TSA) 
system. Tyramide-Flourescein concentrated stock solution (TSA Perkin Elmer kit NEL404) was 
dissolved 1:50 in amplification diluent (part of the kit from Perkin Elmer). 90 µl of this solution 
was applied to each slide and left to incubate for  30min.  Folowing incubation, the cover glass 
was removed in TBS and glass slides were washed twice for 5min in TBS-T. Lastly, nuclei were 
labeled using  DAPI counterstain.  Glass slides  were  washed  with  TBS for  5min and then in 
1:10000 diluted DAPI in TBS for 15min. Folowing staining, sections were consecutively rinsed 
in TBS for 5 and 10min. Sections  were cover-slipped using a glycerol  based mounting medium 
(Vectashield, Vector labs, H1000) and clear nail polish to prevent drying. 
5.3.2 Image acquisition and analysis 
Confocal stacks  were acquired from the CA1 region  of the hippocampus  on a  Leica  TCS  SP8 
laser-scanning microscope with an apochromatic HCX PL APO 20× immersion objective. Each 
stack was composed of 21 horizontal sections. The blue signal (DAPI) was imaged using 405nm 
excitation and a 415 – 490nm bandpass filter, and the orange/red signal (TSA-Cy3) with 555nm 
excitation and a 565 – 665nm bandpass filter. The laser power, gain, and ofset were always set 
individualy for the whole slide. The setings were optimized to obtain bright intra-nuclear foci of 
Arc positive cels. Three images from the CA1 were analyzed from each animal. The identity of 
images  was  blinded  during analysis  by a custom  macro for ImageJ  kindly  provided  by RNDr. 
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Stepan  Kubik  PhD.  The  proportions  of Arc+ to Arc- neurons  were  used to  map  neurons active 
during the test session. The  diference in activities of  CA1  neurons between  QNP treated and 
control groups was analyzed separately using two-way ANOVA.  
 
5.4 Reversal learning on a Carousel arena task 
5.4.1 Drug administrations 
For administration  of al drugs animals  were removed from their  home cage, injected, and 
returned back to the home cage. Specificaly, quinpirole (QNP, SigmaAldrich, Czechia, Cat. No. 
Q102)  was always administered subcutaneously,  30min prior to the experiment at a  dose  of 
0.5mg/kg (dissolved in saline). Clomipramine (CMI) was administered intraperitonealy; always 
1.5h  prior to the experiment at a  dose  of  10mg/kg.  Risperidone (RIS) was also administered 
subcutaneously 1.5h prior to the experiment at a dose of 0.25mg/kg dissolved in a drop of acetic 
acid and diluted with saline; final pH 3.0. Groups that did not have a scheduled administration of 
a  drug at a certain time received saline solution in a  volume appropriate for their  body weight 
(Figure 8). 
 
5.4.2 Experimental design 
5.4.2.1 The Carousel arena 
The Carousel arena was a circular metalic disk (82-cm diameter) elevated one meter above the 
floor with a low rim (Figure 7A). The arena was surounded by 60-cm-high transparent Plexiglas 
wal and rotated at  one revolution/min in a clockwise  direction.  An  unmarked  60º wide to-be-
avoided sector  was  defined in stable room-frame coordinates  on the rotating arena (Figure  7B). 
Whenever a rat entered the sector for more than 300ms, constant-curent regulated electric foot-
shocks (AC, 50Hz, 200 – 600 μA) were delivered at 1200ms intervals until the rat left the sector. 
Shocks were administrated through a subcutaneous needle connector implanted on the back of the 
rat.  The  highest  voltage  drop  of the curent  passing through the rat  was at the  high-impedance 
contact between the paws and grounded metal floor. The appropriate current was individualized 
for each rat in order to elicit a rapid escape reaction but prevent freezing. This aversive procedure 
has been shown to be efective and safe in previous studies (for review see (Stuchlík et al., 2013). 
Each rat was alowed to move freely within the arena boundaries. To locate the sector, rats had to 
navigate purely  using  distant extra-arena landmarks, because  proximal intra-arena landmarks 
(such as scents,  marks  on arena  wals,  urine  marks  or feces)  were  made irelevant  by arena 
rotation.  During acquisition (ACQ) sessions the to-be-avoided sector  was arbitrarily  defined. 
During reversal (REV) sessions the sector  was relocated to the  opposite side  of the arena in 
relation to acquisition sector (rotated  180°),  while the  direction  of arena rotation remained 
unaltered. 
The constant-curent-regulated source that caries curent for the shock (through the 
intradermal  needle  on the rat’s back) also contained a  unit for  powering a light-emiting  diode 
(LED), atached  by a latex  harness to the rat’s  back, signaling the  position  of the rat to an 
overhead camera and a computer. A second  LED  diode  was placed on the arena  periphery 
signaling arena rotation. The analogue signal from an overhead infrared camera was digitized by a 
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DT-3155 card (Data  Translation,  USA) and  processed  by Tracker software (Biosignal  Group, 





Figure 7 | Experimental setup. A. The Carousel arena is a rotating metalic disk 
with a 60° sector defined where rats received a mild electric foot-shock. The sector 
was  not  directly  perceptible,  but  had to  be located  only  using extra-arena cues, 
which were abundant in the experimental room. So as  not to  disturb the rats, the 
experimenter  observed their movement  on a  TV screen from a  diferent room. B. 
Schematic ilustration  of the acquisition (ACQ) and reversal (REV) to-be-avoided 
sectors on the Carousel arena. Arena rotated in a clockwise manner. 
 
5.4.2.2 Procedure – acquisition and reversal testing  
Behavioral testing included three  phases – habituation (HAB), acquisition (ACQ) and reversal 
(REV) (Figure 8). Al phases were composed of 30min sessions conducted every other day. 
Prior to avoidance testing, rats  were  habituated to the apparatus and sensitized to  QNP (HAB 
sessions). If animals were to also receive other pharmaceuticals they were administered prior to 
each  HAB session as  described in chapter 3.4.1 Drug  administrations. After the injection  of 
drugs and elapsed appropriate post-injection interval, each rat was placed into the arena opposite 
to the location of the shock sector, facing the experimenter. Carousel rotation and tracking  was 
turned on immediately after the experimenter left the room. 
The schedule  of drug administration remained the same for the ACQ and  REV  phases, 
when the to-be-avoided sector was already present. Since the arena rotated independently of the 
to-be-avoided sector, the  best strategy for a rat to avoid a shock was to  walk constantly  or 
intermitently in a counter-clockwise direction to avoid being transported into the shock sector by 








Figure 8 | Experimental scheme. Panels A, B and C ilustrate the first experiment - 
testing the efect  of  QNP  on acquisition  of the Carousel  maze task and reversal. 
Panels D, E and F ilustrate the second experiment, testing the efects  of  drugs 
commonly  used in the treatment  of  OCD on cognitive flexibility. Times  of drug 
administration and  numbers  of acquisition and reversal sessions slightly  difered 




5.4.2.3 Measured parameters and statistical analysis 
Behavioral  parameters  were extracted from Tracker software (Biosignal  Group,  USA) and 
analyzed using the open-source Carousel Maze Manager (Bahník, 2013). Output parameters used 
to interpret the Carousel arena task  performance  were: locomotor activity, measured as the 
distance walked throughout the session in meters (movement of arena detected by peripheral LED 
diode was subtracted from total locomotion); number of erors (entrances into the to-be-avoided 
sector); time to the first eror; and the percentage of time spent in the former to-be-avoided sector 
during reversal (in the second  Carousel arena task experiment only the numbers  of erors  were 
analyzed, as the number of errors was a parameter shown to be afected by QNP treatment in the 
first experiment). 
To assure that the  variation in the number  of erors  between  groups  was  not associated  with 
higher locomotion in the QNP group, the presence of corelations between these two parameters 
was also assessed. For corelation analyses Pearson’s product moment coefficient was used. 
To discern types of erors animals made when the to-be-avoided sector was reversed, the 
ratio of the time spent in the to-be-avoided sector during acquisition was assessed for the first day 
of reversal (REV1).  The calculation  was similar to  one  described in  detail  by  Petrasek and 
coleagues (Petrasek et al., 2013). In short, the arena was divided into six 60°-sectors. Apart from 
sectors that served as a to-be-avoided sector in acquisition and reversal there  were four other 
sectors,  n1  –  n4, located in  pairs  between the acquisition and reversal to-be-avoided sectors, 
where shocks  were never given.  The perseverative  behavior  was indicated  by the ratio  of time 
spent in the acquisition to-be-avoided sector  divided  by the average time spent in always-safe 
sectors (A / (n1– n4 + A). The reversed to-be-avoided sector was excluded from the calculation 
because the electric shock affected the time spent in this sector.  Since  perseveration can  be 
quickly  overridden  by re-learning the  new sector  position, only the initial  10min of the first 
reversal session were analyzed.  
Every  batch  of rats  used in this study included rats that  did  not learn how to prevent 
entering a to-be-avoided sector. Rats that did  not acquire an efective learning strategy  during 
acquisition training were excluded from the REV phase (it is not possible to reverse learning that 
did  not take  place). The criterion for the exclusion  of rats in reversal was more than  10 errors 
during the last 30min session (ACQ4 or ACQ5 depending on the experiment). 
For the assessment of learning in ACQ and REV sessions, a two-way repeated measure ANOVA 
was conducted  using the ‘sessions’ as a repeated  within-subject  measure and ‘group’ as a 
between-subject factor (QNP vs. SAL). When a session x group interaction was significant it was 
folowed by simple-efects analysis. If necessary, acquisition learning was analyzed twice,  once 
with included and once with excluded ‘non-learners’. This was to uncover any bias that could be 
present  due to the exclusion  of  non-learning rats (i.e. in situations  where ‘non-learners’ had a 
greater impact in one group than in the other). When data were not normaly distributed or did not 
meet the assumption of homogeneity of variance, the appropriate transformation was conducted. 
If no transformation was able to transform the data into a parametric data set, diferences between 
the  groups  were assessed  by a  non-parametric  Mann-Whitney sum ranks test  with  Bonferroni 
corection applied to the level of test significance. Al statistical tests were considered significant 
at the threshold of p<.05 (two tailed). Al statistical analyses were conducted using SPSS software 




5.5 Hippocampus independent two-way active avoidance in shutle boxes in 
quinpirole treated rats and augmentation with clomipramine 
5.5.1 Two-way active avoidance 
The apparatus (Multi  Conditioning system,  TSE, Germany)  was a sound  proof,  wel-lit (10Lx) 
and ventilated 90 x 90 x 90cm box with plain black non-transparent wals. The floor consisted of 
a metalic grid made of 0.5cm diameter stainless steel rods, with centers spaced 1.5cm apart. This 
grid was used to deliver electric shocks to animals. The box was divided into two compartments 
by a black insert with a 7 x 7cm cutout opening in the middle. In this task, a rat had to make an 
association between an acoustic conditioned stimulus (CS; 5s tone; 70db) and an unconditioned 
stimulus (US; an electric foot shock; 0.5mA; 500Hz, AC) separated by a 10 sec time gap. Each 
session began with a 60s habituation period. Immediately after habituation, CS was administered. 
US folowed after a 10s delay. CS and US were always administered in the compartment where 
the animal  was  present at that  moment.  The electric foot shock (US) was terminated when the 
animal left the compartment. In case the animal did not leave compartment during the foot shock 
it  was automaticaly terminated after  5s.  The inter-trial interval (ITI)  was  variable,  with an 
average of 30s (± 60%).  
 
5.5.2 Behavioral procedure in the two-way active avoidance task 
30 daily CS-US trials were performed for 5 consecutive days. Prior to each experiment, animals 
were sensitized to  QNP and  CMI for  10 consecutive  days in their  home cage. During testing 
animals also received drugs in their  home cage and  were placed into the apparatus  1.5h after 
CMI/SAL administration and 30min after QNP/SAL administration. Al drugs were administered 
at  doses described above in chapter 3.4.1  Drug  administrations. There  were four treatment 
groups in the experiment: QNP alone, (QNP, n = 6); QNP in combination with CMI, (QNP+CMI, 
n = 6); CMI alone, CMI (n = 6); and control, (SAL, n = 7). 
 
5.5.3 Measured parameters and statistical analysis 
Key  parameters  measured  were the  number  of escapes after the acoustic conditioned stimulus 
(conditioned stimulus escape; CSE) and escapes after electric foot shocks (unconditioned stimulus 
escape; USE). The ratio of USE to CSE was analyzed using the formula USE / (CSE + 1). Also, 
the number of escape failures was recorded. Three-way ANOVA was used to analyze the results, 
with ‘group’ (CMI/SAL  or QNP/SAL) a  between-subject  variable and ‘time’ a  within-subject 
repeated measure variable. Al statistical tests were considered significant at the threshold of p < 
.05 (two-tailed). Al statistical analyses were conducted using SPSS software (SPSS Inc., version 
23, USA).  
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6 RESULTS  
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6.1 Enriched open-field checking in QSM 
To determine the stability of checking behavior we analyzed the checking behavior of SAL (n = 
13) and QNP (n = 13) treated rats. We expected QNP animals to show a more uniform session-to-
session preference of zones compared to SAL animals. We utilized a general mixed linear model 
to determine if there were overal efects of ‘treatment’ (QNP or SAL) ‘session’ (sessions 1 – 10) 
and ‘re-coded zone’ (‘A’-‘F’).  Session and zone  were entered as repeated  measures into the 
model. The analysis revealed significant efects of treatment, session, zone, sesion  x zone, 
session x treatment, zone x treatment and session x zone x treatment interactions (Table1, panel 
A). We the  performed a  highest  order, three-way interaction (session  x zone  x treatment) by 
simple analysis  of  variance (ANOVA) to analyze the checking frequency  of zones for each 
treatment  within each session separately. In SAL treated animals there  was  no significant 
diference between zone visits in any of the sessions (Table 1B, Figure 9A). On the other hand, in 
the QNP  group  visits to zones  were significantly  diferent in sessions  1,  4,  5,  6,  7,  8,  9 and  10 
(Table 1C). The Bonferoni post-hoc test revealed that significant tests in the QNP treated group 
were due to significantly more visits to zone ‘A’ compared to zone ‘B’ in sessions 1, 5, 7, 9 and 
10; zone ‘A’ compared to zone ‘C’ in sessions 1, 5, 7, 8, 9 and 10; zone ‘A’ compared to zone ‘D’ 
in sessions  4 to 10; zone ‘A’ compared to zone ‘E’ in sessions 1 and  4 to  10; and zone ‘A’ 
compared to zone ‘F’ in sessions 1 and 4 to 10 (Table 1C, Figure 9B). Clearly, the post-hoc test 
revealed very similar sets of diferences in most of the sessions. Moreover, during the last session 
QNP animals showed significantly  more  visits to zone ‘B’ compared to zones ‘D’, ‘E’ and ‘F’ 





Figure 9 | Checking of zones in the enriched open-field over 10 sessions. Panel A 
shows visits to open-field re-coded zones in SAL treated rats, where no patern of 
between-session checking  developed.  Panel B shows visits to open-field re-coded 
zones in  QNP treated rats.  Significant  diferences between visit frequencies are 
based on a Bonferoni post-hoc test with the level of accepted significance set to p < 
0.05; denoted by an asterisk (*). Panels C and D show a typical trajectory of SAL 




Table 1 | Important  outputs from the SPSS  general  mixed  model (A) and 




6.2 Arc expression during checking behavior in the CA1 area of the hippocampus  
In this experiment  we  visualized the activity  of  brain regions implicated in  OCD  during active 
checking  behavior  by  utilizing fluorescent in situ  hybridization (FISH).  Namely,  we  were 
interested in Arc mRNA transcription in QNP treated and SAL treated rats after a 5min exposure 
to the enriched open-field arena. Arc mRNA is an established  marker  of  neuronal  plasticity-
related activity (Galo et al.,  2018) and a reliable  marker  of  heightened  neuronal firing (Barth, 
2007). 
We  used a factorial  ANOVA to analyze the  percent of Arc positive nuclei (Arc+) in the 
CA1 area of the hippocampus. Environment (OF or CC) and treatment (QNP or SAL) were used 
as between-subject measures. We found a significant efect of environment [F(1,23) = 51.527, p < 
0.001], treatment [F(1,23) = 17.115, p<0.001], as wel as a environment x treatment interaction 
[F(1,23)  =  16.828,  p<  0.001].  We  used independent sample t-tests to compare the efect  of 
treatment in each of the environments to dissect this interaction term. This analysis revealed that 
QNP treated animals had 11% Arc+ nuclei while SAL treated rats had 30% Arc+ nuclei [11.2% in 
QNP and 30.1% in SAL animals; t(15) = 5.586, p<0.001]. In baseline conditions (CC) both QNP 
and SAL treated animals had less than 5% Arc+ nuclei [4.1% in QNP and 4.2% in SAL animals; 
t(8) = 0.062, p = 0.952] (Figure 11B). This <5% baseline Arc+ fraction in cage-control animals is 
in line with previous results acquired in our and other laboratories (Guzowski and Worley, 2001; 
Buchtová et al., 2016). 
Next, we assessed if checking behavior remained intact in a 5min session prior to sacrifice 
compared to the final 50min checking session. As, from the rats’ perspective the beginning of the 
5min session  was indistinguishable from the previous  50min sessions,  we expected that the 
patern of zone checking would be very similar to the previous final 50min session in QNP treated 
rats. We found that despite the shorter length patern of checking, the 5min session was indeed 
similar to the preceding 50min sensitization session (Table 2A and B, Figure 10C). To be able to 
compare checking in final 50min session and 5min session  preceding sacrifice, the numbers  of 
visits to each zone were standardized.  Next, we conducted a repeated  measure analysis  of 
variance (RM-ANOVA). We then assessed a significant zone x treatment interaction using one-
way  ANOVAs for each session and treatment separately. In  SAL treated animals there  was  no 
significant diference between zone visits in either the final 50min checking session or the 5min 
session prior to sacrifice (Table 2B, Figure 11C). In QNP treated rats there was a significant effect 
of zone in both the final 50min checking session and in the 5min session prior to sacrifice (Table 
2B). Namely, the significance stemmed from significantly higher visits to zone ‘A’ compared to 
zones ‘E’ and ‘F’ in both the final 50min checking session and in 5min sessions, and significantly 
more visits to zone ‘A’ compared to zones ‘B’, ‘C’ and ‘D’ and ‘B’ compared to zones ‘D’, ‘E’ 
and ‘F’ in the 50min checking session. 
To exclude the possibility that differences in the numbers of Arc+ nuclei were driven by 
diferences in locomotion, we compared locomotion  between  QNP and  SAL treated animals in 
the 5min session  prior to sacrifice. Despite the fact that  QNP treated rats  displayed  higher 
locomotion on average compared to SAL treated rats, the independent sample t-test revealed that 






Table 2 |  Repeated  measured analysis  of  variance (RM-ANOVA,  panel A) and 





Figure 10 | Panel A depicts the location of sample colection (the CA1 arena of the 
hippocampus) and a representative acquired image.  Panel B shows the percent  of 
Arc+ neurons in the CA1 of the hippocampus. An asterisk (*) denotes significance 
at p < 0.05. QNP treated rats had three times lower numbers of Arc+ cels compared 
to SAL treated rats (p < 0.001). Panel C shows checking of zones during the final 
50min checking session and the 5min session that preceded animal sacrifice, and 
Arc+  detection (mean  ± standard eror  of  mean).  Panel D shows that in the 5min 
session  prior to sacrifice and Arc detection there  was  no statistically significant 




6.3 Reversal learning on the Carousel arena in quinpirole treated rats 
Since we found that QNP-treated rats has fewer Arc+ cels in the CA1 area of the hippocampus 
compared to SAL rats, we hypothesized that QNP-treated rats may be specificaly impaired in a 
hippocampus  dependent task such as the Carousel arena task. In this experiment we compared 
acquisition and reversal learning of the Carousel arena task between rats treated with QNP (QNP, 
n = 10) and control rats treated with saline (SAL, n = 11). 
Two rats from each group did not reach the learning criterion of having less than 10 erors in the 
last acquisition session.  These rats  were  not included in the reversal  phase.  Specificaly, in the 
SAL group one of these rats froze throughout most of the session and the second did not find an 
efective avoidance strategy. In the QNP group neither of the two excluded rats appeared to seek 
an efective avoidance strategy (visual observation). 
 
6.3.1 Locomotion 
Al QNP and SAL treated rats were included in the assessment of locomotor activity in four ACQ 
and four REV sessions  by repeated  measure two-way  ANOVA (with the excluded animals 
included). ACQ and  REV were analyzed together by repeated  measures ANOVA.  Because 
Mauchly’s test indicated that the assumption of sphericity had been violated, (χ2 (27) = 66.99, p < 
.001), degrees of freedom were corected using the Greenhouse-Geisser estimate of sphericity (ε = 
.45) for tests that included a repeated measure. Importantly, QNP treated rats showed significantly 
higher overal locomotor activity compared to the control  group [F(1,16)  =  234.05  p  < .001]. 
Moreover, overal locomotor activity varied throughout sessions [F(3.26, 52.15) = 2.95 p < .05]. 
Also, the analysis showed a significant efect of the sessions x groups interaction [F(3.26, 52.15) 
=  3.78  p  < .05]. Subsequent analyses to  dissect the effects  of this interaction term showed a 
significant increase in locomotion  between the third  ACQ session (ACQ3) and fourth  ACQ 
session (ACQ4) [session: F(1,16) = 9.69, p < .01; interaction: F(1,16) = 9.17, p<.01], and between 
acquisition day 4 (ACQ4) and the first day of reversal (REV1) [session: F(1,16) = 11.25, p < .01; 
interaction: F(1,16) = 9.49, p < .01]. Because a visual inspection of the control group did not show 
any fluctuations (Figure 11) in locomotor activity, the apparent  up-regulation  of activity in the 







Figure 11 | Locomotion (meters/session) in quinpirole treated rats (QNP) compared 
to control rats treated with saline (SAL). There was significantly higher locomotion 
in  QNP-rats compared to their controls during al sessions (ACQ1 – REV4).  Data 
are  presented as  mean  values  ±  SEM.  Asterisks (*) denote a significant simple 


















6.3.2 Acquisition and reversal learning 
6.3.2.1 Acquisition – number of errors 
Learning  behavior  was analyzed for acquisition and reversal learning separately. Acquisition 
learning (ACQ1  – ACQ4)  was analyzed  with al cases included (to  determine if there was a 
significant diference in overal learning capability between groups). In this case, the distribution 
of number of errors was not normal and no transformation was able to normalize them. Therefore, 
the  Mann-Whitney test  was  used to compare the two experimental  groups in each acquisition-
learning day. The Bonferroni corection was applied to control for a family-wise eror caused by 
the high number of comparisons (the new significance threshold was calculated to be p< 0.013). 
No significant  diferences in the number  of erors were  detected  between  groups in any  of the 
acquisition sessions [ACQ1: U = 42.00, z = -.92, ns; ACQ2: U = 54.50, z = -.04, ns; ACQ3: U = 
41.50, z = -.97, ns; ACQ4: U = 42.50, z = -.90, ns] (Figure 12A). The results show there was no 
diference  between  QNP and SAL groups in acquisition learning  with al rats included in the 
study. 
Next, acquisition learning was assessed with only rats that met the criteria to be included 
in reversal learning (less than 10 erors in the last acquisition session). After the exclusion of non-
learners (> 10 erors), the data showed a normal distribution and equal variances after logarithmic 
transformations, which alowed a two-way repeated measure ANOVA to be conducted. ‘Session’ 
was considered a repeated  measure and ‘treatment group’  was considered a  between-subject 
factor.  Because  Mauchly’s test indicated that the assumption  of sphericity  had  been  violated 
[χ2(5)  =  42.39,  p  < .001)],  degrees  of freedom  were corected  using the  Greenhouse-Geisser 
estimate  of sphericity [ε  = .40)] for tests that included repeated  measures.  Overal there  was a 
significant decrease in the number of erors throughout sessions [sessions: F(1.19,17.88) = 26.59, 
p  < .001],  but there  was  no significant  diference  between  QNP and saline treated  groups 
[treatment: F(1,15) = 39.95, ns] or a sessions x treatment interaction [interaction: F(1.19,17.88) = 
0.93,  ns] (Figure  12B).  Therefore, there  was  no significant diference  between  groups in 







Figure 12 | Number  of errors (entrances into the to-be-avoided sector during 
30min) in the Carousel arena during acquisition sessions (ACQ1 – ACQ4) when 
al rats were included (A) and with non-learners excluded (B) and in four reversal 
sessions (REV1  – REV4) (C). There  was  no  diference in  Carousel arena 
acquisition learning  between  QNP and  SAL treated rats (A).  Also, there  was  no 
diference between QNP and SAL treated rats that were tested in reversal (B). The 
post-Hoc test revealed a significantly more erors in QNP treated rats compared to 
Sal treated rats in first day of reversal testing (REV1, p < 0.001) (C). D shows the 
percentage  of time spent in the former shock sector compared to the mean time 
spent in always-safe sectors during first 10min of reversal (REV1). QNP-treated rats 
showed a significantly higher percentage of time spent in the former to-be-avoided 





6.3.2.2 Reversal – number of errors 
Reversal learning is used as a proxy of cognitive flexibility in both humans and animal models. 
Since  QNP treatment induces rigid  behavior, we expected that  QNP treated rats would be 
specificaly impaired in the reversal part of the Carousel arena task. 
Two-way repeated  measure  ANOVA  was conducted  on the  number  of erors in four reversal 
sessions (REV1-REV4,  only rats  which achieved less than  10 erors in  ACQ4  were included) 
(Figure 13C). There was a significant decrease in erors throughout the sessions [F(1.939, 25.204) 
=  5.444  p  < .05], even after  degrees  of freedom  were corrected  by the  Greenhouse-Geisser 
estimate  of sphericity [ε  = .65] because the assumption  of sphericity  was significantly  violated 
[χ2(5) = 18.673, p < .05]. Importantly, QNP-treated animals made significantly more errors than 
SAL animals [F(1,13) = 31.72, p < .001]. The sessions x treatment interaction was also significant 
[F(1.94, 25.20) = 4.61, p < .05]. To further analyze this interaction term a simple efect analysis 
was conducted, which showed that QNP animals made significantly more erors only on the first 
day of reversal [REV1: F(1,13) = 11.18, p < .01; other sessions: REV2 F(1,13) = 2.14, ns; REV3 
F(1,13) = 0.73, ns; REV4 F(1,13) = 0.02, ns]. 
 
6.3.2.3 Perseverative behavior 
More details in the diferences in reversal learning behavior can be seen by an analysis of the time 
spent in the former to-be-avoided sector after the change of shock location, defined by the ratio 
between the time spent in the former to-be-avoided sector and the time spent in always-safe 
sectors (al sectors but the reversed to-be-avoided sector). Spending less time in the former to-be-
avoided sector indicates a high perseverative behavior, as the animal is stil avoiding the previous 
to-be-avoided sector. We expected that QNP-treated animals would show increased perseveration, 
similarly as  was shown in another task in  QNP treated animals (Einat and  Szechtman,  1995). 
Intriguingly, the t-test showed that control rats spent only 5.12 ± 1.7% of the time in the former 
shock zone while QNP-treated rats spent up to 13.32 ± 2.5% in the former shock zone in the first 
10min of the first reversal session [REV1: t(15)= -2.76, p < .05] (Figure 13D). Therefore, counter-
intuitively, control animals showed more perseveration than QNP treated animals.  
 
6.3.2.4 Time to the first error 
‘Time to the first eror’ describes the latency (in seconds)  of the rat to enter the to-be-avoided 
sector, and is considered to  be an indicator  of long-term  between-sessions  memory (Stuchlík et 
al., 2013). Values of ‘time to the first eror’ were non-parametricaly distributed in both QNP and 
SAL  groups and  no transformation  was capable  of  normalizing them.  Therefore, the  non-
parametric Mann-Whitney test had to be used to analyze the data for each day separately (both in 
acquisition and in reversal). The Bonferoni corection was applied to control for the family-wise 
eror caused by the high number of comparisons (the new significance threshold was calculated to 
be  p<  0.008).  Despite an apparent trend towards  beter long-term  memory retention in control 
animals compared to  QNP animals (Figure 13), it was not statisticaly significant [ACQ2:  U  = 
53.00, z  = -.14,  ns;  ACQ3:  U  =  37.00, z  = -1.27,  ns;  ACQ4:  U  =  27.00, z  = -1.97,  p  =  0.049; 
REV2: U = 52.00, z = -.21, ns; REV3: U = 44.50, z= -.42, ns; REV4: U = 49.00, z = -.42, ns]. In 
summary, after the family-wise corection  of significance threshold, there  was  no significant 







Figure 13 | Time to the first error (mean seconds  ± S.E.M.) in experiment  1 
(ACQ2–ACQ4;  REV2–REV4).  There  was  no significant diference  between  QNP 
and SAL treated rats at p < 0.05.  
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6.4 Efects of clomipramine and risperidone on Carousel arena performance in 
quinpirole treated rats 
This experiment was conducted to assess if the most commonly used OCD treatments improve the 
cognitive flexibility  deficit in reversal learning that was  observed in the previous experiment. 
CMI had already been shown to reduce checking behavior in QNP treated rats (Szechtman et al., 
1998); therefore we hypothesized that it may be also efective in improving Carousel arena task 
reversal.  We included a combination  of  CMI and  RIS as an augmentation to  QNP, as a 
combination  of antidepressants and antipsychotics  was shown to  be efective in improving 
symptoms in treatment resistant OCD patients (Dold et al.,  2013).  To test the efects  of these 
‘treatments’ on the QNP-induced reversal-learning deficit, we used a slightly modified Carousel 
arena task protocol (5 acquisition sessions and 3 reversal sessions), with the folowing treatment 
groups: QNP treated rats (QNP; n =15), QNP treated rats augmented with CMI (QNP+CMI, n = 
11); QNP treated rats augmented with RIS (QNP+RIS; n = 11); QNP treated rats augmented with 
CMI and RIS together (QNP+CMI+RIS;  n  = 11), and saline treated control animals (SAL;  n  = 
10). 
 
6.4.1 Acquisition – number of errors 
The  number  of erors to the to-be-avoided sector  was  used as the main  output  parameter. The 
numbers  of erors were not  normaly  distributed in either QNP or SAL  groups, so logarithmic 
transformation was used to achieve normality. The two-way ANOVA showed a significant effect 
of treatment [F(1,59)  =  941.880,  p  = 0.019].  Hochberg’s  post  hoc test showed that only the 
quinpirole treated  with clomipramine  group  made significantly  more erors compared to the 
control  group [QNP+CMI:  p  =  0.038].  Also, there  was a significant  overal  decrease in errors 
during acquisition learning [F(4,236) = 101.599, p < 0.001]. A comparison of performance across 
acquisition sessions showed that between each set of sessions there was a significant improvement 
[ACQ1/ACQ2:  F(1,59)  =  92.862,  p  <  0.001,  ACQ2/ACQ3:  F (1,59)  =  14.513,  p  <  0.001, 
ACQ3/ACQ4: F(1,59) = 5.899, p = 0.018, ACQ4/ACQ5: F(1,59) = 20.530, p < 0.001]. 
Moreover, there  was a significant  group  x session interaction [F(20.236)  =  1.741,  p  = 
0.028].  Simple efects analysis explained this interaction as arising from significant differences 
between  groups in the first acquisition session [F(5,59)  =  2.25,  p  =  0.061] and in the fifth 
acquisition session [F(5,59) = 4.81, p = 0.001]. Hochberg’s post hoc test of the first acquisition 
session revealed worse performance of the QNP+CMI group compared with the QNP+CMI+RIS 
group (p = 0.039), the group with the least number of erors. On the fifth session, the last day of 
acquisition, the post-hoc test showed worse performance of the QNP+RIS group [p = 0.038] and 
QNP+CMI group [p = 0.001] compared to controls (SAL). Results are displayed in Figure 15A. 
In the  group  of rats receiving a combination  of QNP+CMI, only four animals  met the 
criterion  of less than ten erors (n  = 4); therefore the whole  group  was excluded from the 
statistical analysis of reversal learning. Other groups had only slightly decreased sample sizes due 
to the exclusion  of animals  based  on this criterion (QNP,  n  = 10;  QNP+CMI+RIS  n  =  9; 
QNP+RIS n = 8; SAL, n = 9). Analysis of the number of animals excluded for reversal did not 
show any significant diference between groups χ2(5) = 8.735, p = 0.122 (the QNP+CMI  group 
was omited from this analysis). 
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6.4.2 Reversal – number of errors  
The  numbers  of erors in each  group in reversal learning  were  not  normaly  distributed, and so 
were log transformed to achieve normality. The two-way ANOVA showed a significant efect of 
session [F(2,66) = 46.081, p ˂ 0.001], and a significant decrease in erors between the REV1 and 
REV2 sessions [F(1,33) = 38.297, p ˂ 0.001] as wel as between the REV2 and REV3 sessions 
[F(1,33) = 19.774, p ˂ 0.001]. Surprisingly, the effect of treatment was not significant [F(3,33) = 
0.296,  p  =  0.828], suggesting that there  was  no  diference in reversal  performance  between 
groups.  However, the  group  x session interaction  was significant [F(6,66)  =  2.817,  p  =  0.027]. 
Simple efect analysis explained this interaction as arising from the diference between the tested 
animal  groups  during the first reversal session [REV1;  F(3,33)  =  3.89,  p  =  0.013].  Hochberg’s 
post hoc test showed that the significant diference in the first reversal session was caused by the 
higher number of erors made by the QNP treated rats compared to the control group [p = 0.010]. 
This experiment replicates  our  previous findings  where  we found that  QNP treated rats made 
more erors compared to the control  group specificaly in the first reversal session.  Results are 





Figure 14 | Number  of errors in  Carousel  arena acquisition (panel A; ACQ1-
ACQ5) and reversal (panel  B; REV1-REV3).  A. Comparisons of numbers of 
erors (entrances to the to-be-avoided sector) in al treatment  groups  during 
acquisition.  Throughout al sessions, the  group receiving the combination 
QNP+CMI made significantly more erors than the control group. Moreover, in the 
first session the  QNP+CMI  group made significantly  more errors than the  group 
treated  with a combination  of  QNP+CMI+RIS.  On the last  day  of acquisition, the 
groups treated with QNP+RIS and QNP+CMI made significantly more errors than 
the SAL group.  The average  number  of erors is  displayed  ±SEM.  *  denotes a 
significant difference at p < 0.05. B. Comparisons of number of erors (entrances to 
the to-be-avoided sector) between al treated groups during reversal. In the reversal 
phase  of the experiment there  was significant impairment in the QNP  group 
compared to the SAL group.  The average  number  of erors is  displayed  ±SEM.  * 
denotes a significant diference from the control group at p < 0.05. 
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6.5 Hippocampus-independent two-way active avoidance in shutle boxes in 
quinpirole treated rats and augmentation with clomipramine 
Since we had discovered impaired acquisition learning in animals treated with a combination of 
QNP and  CMI,  we  decided to test the efects of  CMI and  QNP in a  diferent task.  We  were 
interested if cognitive impairment  was  general  or specific for the hippocampus-dependent 
Carousel arena task. To this aim, we used two-way active avoidance conditioning in shutle boxes, 
a task in which successful performance is facilitated by a lesion of the hippocampus (Wang et al., 
2015). We hypothesized that QNP treated rats and QNP treated rats augmented with CMI would 
show superior  performance compared to control rats, because our previous  data showed that 
hippocampal function was likely compromised in QNP, CMI and QNP+CMI groups of animals. 
We used rats treated with QNP (QNP; n = 6), rats treated with CMI alone (CMI; n = 6), animals 
treated with a combination of QNP and CMI (QNP+CMI; n = 6) and saline treated controls (SAL, 
n = 7). 
Three-way ANOVA was used to analyze results of the active avoidance shutle box test. 
Between-subject  measures  were  QNP and  CMI and the  within-subject  measure  was the session 
number (session  1  – session  5).  Al  data  was logarithmicaly transformed to  meet  parametric 
assumptions. 
The  most important  parameter was the  number  of conditioned escapes (CSE). A CSE 
occurs when an animal escapes after the sound is presented (before the foot shock). There was an 
overal increase in the number of escapes with training [sessions: F(4,84) = 15.661, p < 0.001]. 
Importantly, there was a significant increase in conditioned escapes (CSE) when QNP was used 
[F(1,21) = 35.722, p < 0.001], while CMI did not significantly afect the number of CSEs [F(1,21) 
= 1.080, p = 0.310]. As Figure 15A shows, both groups receiving QNP (QNP and QNP+CMI) had 
higher  numbers of  CSE. These results indicate  beter  performance in this  hippocampus-
independent task  when animals  were treated with QNP. In line  with the observed  decrease in 
hippocampal function,  QNP appears to  produce a similar efect as a hippocampal lesion in this 
task. 
The  number  of  unconditioned escapes (USE)  was assessed in the same  manner. A  USE 
occurs when an animal escapes to the next chamber after it is foot shocked. There was no change 
in the number of USE throughout the training [sessions: F(4,84) = 1.611, p = 0.179]. Also, neither 
QNP nor CMI afected the number of unconditioned escapes [QNP: F(1,21) = 2.704, p = 0.115; 
CMI: F(1,21) = 2.786, p = 0.110] (Figure 15B).  
Analysis  of the ratio  of  USE to  CSE (which we considered a true indicator  of learning) 
showed that there were significantly more conditioned escapes than unconditioned escapes with 
time [F(1,84) = 14.640, p < 0.001]. While CMI did not have an effect on the USE to CSE ratio 
[F(1,21) = 0.832, p = 0.372], QNP significantly increased the number of conditioned escapes in 
favor  of  unconditioned escapes [F(1,21)  =  16.781,  p  =  0.001]. Both  groups treated  with  QNP 
(QNP and QNP+CMI) had a lower USE to CSE ratio, indicating beter performance in this task 
(Figure 15C). 
Lastly, the number of escape failures was also analyzed. There was a significant reduction 
in the  number  of times  when an animal  did  not react to either a conditioned  or  unconditioned 
stimulus [session: F(1,84)  =  4.082,  p  =  0.005].  Although there  was  no significant efect  of 
treatment  on the  number  of escape failures [QNP:  F(1,21)  =  3.215,  p  =  0.087;  CMI:  F(1,21)  = 
2.399, p = 0.136], there  was a significant CMI x QNP interaction [F(1,21) = 5.855, p = 0.025]. 
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When  CMI,  QNP  or  both  were  present, animals  displayed equivalently low levels  of escape 
failures (Figure  15D), while saline treated controls (SAL) showed a higher incidence  of non-
responding. 
In summary, clomipramine  decreased  non-responding  behavior  without afecting 
conditioned escapes,  while  QNP  both  decreased  non-responding  behavior and increased the 




Figure 15 | Two-way  active  avoidance in shutle  boxes. A. The  number  of 
conditioned escapes (CSE). B. The number of unconditioned escapes (USE). C. The 
ratio  of  unconditioned escapes to conditioned escapes (USE / (CSE  +  1)). D. The 
number  of escape failures.  There  was a significant increase in the  number  of 
conditioned escapes  when  quinpirole  was included, and significantly reduced 
freezing  when quinpirole, clomipramine,  or  both were included.  The average 
number of erors is displayed ± SEM. Significances are not included, because data 
was analyzed by three-way ANOVA.  
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7 GENERAL DISCUSSION  
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This dissertation thesis has focused on a detailed analysis of inflexible behavior displayed by the 
quinpirole sensitization model (QSM) of Obsessive Compulsive Disorder (OCD). We showed that 
rats treated with QNP display stable checking behavior in an enriched open-field arena, and these 
checks  were not limited to one  particular zone. Unprecedentedly, we observed that  during 
stereotypical checking behavior the hippocampal CA1 region is less active compared to the CA1 
region of control animals  during exploration  of the same enriched  open-field arena.  Supporting 
the  deficiency of hippocampal function in QNP sensitized rats, we shown that QNP treated rats 
are impaired in the hippocampus-dependent Carousel arena task. One established OCD treatment 
– a combination of clomipramine and risperidone – reversed this deficit. Moreover, we confirmed 
the presence of a selective hippocampal deficit by showing that QNP treated rats are superior in a 
hippocampus-independent active avoidance task.  Based  on these results,  we suggest that 
hippocampal dysfunction may be central to the induction of stereotypical behavior and relevant to 
OCD. 
 
7.1 Between-session stability of checking behavior 
Here we confirmed that rats treated with QNP display stereotypical checking as described by the 
inventor of this  OCD animal  model –  prof. Szechtman (Szechtman et al.,  1998).  Stereotypical 
checking, typical  of QNP sensitized animals, is traditionaly observed in an open-field arena 
enriched  with  2  – 3  objects.  Animals  displaying checking  behavior  usualy repeatedly  visit 
(‘check’) these objects and also repeatedly visit corners of the arena (together caled zones). We 
reproduced this checking behavior in a smaler arena (1 x 1 m compared to 2 x 2 m in original 
study). In many studies, visits to the ‘home base’ – the  most frequently  visited zone  – is 
considered the main  measure  of stereotypical checking. However, OCD rituals are  usually 
complex (Swedo et al., 1989). To determine if a more complex patern of checking activity was 
present we extended the analysis and examined the stability of preferences for al zones between 
al consecutive sessions.  We found that  QNP treated rats displayed the same  patern  of 
preferences for zones in al sessions, not only for the ‘home base’. QNP treated rats also displayed 
the same patern of checking when the session in the enriched open field was much shorter: i.e. 
during the 5min sessions that  preceded sacrifice for IEG Arc expression analysis. This is 
important, as  CA1  hypoactivity emerges  only  during stereotypical checking and  not  during 
baseline conditions (cage controls or saline-treated rats in the enriched open-field arena).  
 
7.2 Decreased hippocampal Arc expression during checking behavior in the 
enriched open-field arena in QSM 
To measure the activity of the hippocampal CA1 region in the QNP sensitization model of OCD 
we used in situ hybridization of Arc mRNA. Although using IEG expression restricts output to a 
binary characterization  of  previously active  or inactive neurons (patern, rate and spatial 
specificity  of firing cannot  be captured), IEG expression  profiles reveal important information 
about which neurons were recruited during a given behavioral experience. In the present study we 
observed a robust  decrease  of Arc expressing  neurons in the CA1  of the hippocampus (a 60% 
decrease of Arc+ nuclei compared to controls) during stereotypic checking in the enriched open-
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field arena in QNP treated rats. In rats that were repeatedly treated with QNP, but did not execute 
checking  behavior, CA1 activity  was comparable to control animals.  This finding stresses the 
importance of the environmental dependency of QNP sensitization (Szechtman et al., 1993). As 
mentioned above, although the activity of neurons was measured during a shorter period than the 
‘standard’ sensitization session (5min compared to 50min), the patern of stereotypical checking 
remained very similar. Assessing IEG expression folowing 5min short sessions had an important 
advantage in equalizing locomotor activity  between  groups, as control animals  were  usualy 
hypoactive later into the session. In other studies that measured regional brain activity using local 
cerebral  glucose utilization, the possible efect  of locomotion  on study  outcome has  not been 
accounted for (Carpenter et al., 2003). Yet, our findings are in line with findings of studies that 
examined brain activity in QNP treated rats without checking activity. The [18F]-FDG uptake was 
decreased  by  19% in the hippocampus in anesthetized  QNP treated rats measured  by 
MicroPET/CT imaging (Servaes et al.,  2016), and a statisticaly insignificant  decrease  of 
hippocampal cerebral  glucose  utilization  was  observed in QNP treated rats  when rats  were 
sensitized in locomotor activity boxes (Carpenter et al., 2003). 
We suggest three  possible  mechanisms  by  which  QNP could induce  decreased  hippocampal 
activity: 
 
1.  Decreasing the overal  dopamine tone induced  by the QNP-mediated inhibition of 
dopamine release from the VTA. 
2.  Directly altering  hippocampal function  by the activation  of  D2 receptors in the 
hippocampus. 
3. QNP-mediated decreasing of the activity of regions projecting to the hippocampus. 
 
The first  possibility is that the decrease  of Arc-expressing  neurons in the CA1 results from 
decreased  overal  dopamine tone. It has repeatedly been described that  QNP has a  biphasic 
efect  on an animal’s brain. First, D2 autoreceptors expressed  by VTA  neurons are activated  by 
QNP. Activation  of VTA  D2 autoreceptors inhibits dopamine release from  dopaminergic 
terminals (Sulzer et al., 2016). Hypo-locomotion observed 5 – 30min folowing QNP injection has 
been atributed to the activation  of  D2 autoreceptors (Skirbol et al.,  1979).  Conversely,  hyper-
locomotion, which occurs during time frame when our experiments were conducted (30min and 
longer), has  been atributed to the stimulation  of  postsynaptic  D2 receptors (Wu et al.,  1993). 
However, the inhibition  of dopamine release from VTA persists alongside the activation  of 
postsynaptic auto-receptors (Sesia et al.,  2013). While the  overal efect  of QNP is complex, a 
reduction  of  dopamine tone  by itself could reduce Arc expression, and it has  been shown that 
tonic dopamine is important for both the encoding and persistence of memory traces (Lisman and 
Grace, 2005; Bethus et al., 2010; Shohamy and Adcock, 2010). A lack of dopamine induced by 
D2 autoreceptors activation in the VTA could thus result in an overal decrease of encoding in the 
hippocampus and thus reduce the expression of plasticity-related genes such as Arc. 
The second  possibility is that  QNP  decreases Arc expression directly  by  acting  on  D2 
receptors expressed in the hippocampus. D2 receptors are widely expressed in the hippocampus 
in two specific  neuronal subtypes – glutamatergic  mossy cels (Eter and  Krezel,  2014) and 
inhibitory GABAergic cels (Gangarossa et al., 2012; Puighermanal et al., 2015). Activation of D2 
receptors  by  quinpirole atypicaly induces an increase in the excitability of  mossy cels in the 
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hippocampal hilus (Eter and  Krezel,  2014).  Although the exact function  of  mossy cels is 
curently unknown, it was shown that they send excitatory projections to both granule cels in the 
dentate gyrus and to inhibitory interneurons mediating feed-forward inhibition (Scharfman, 2018). 
The  net effect  of the activation  of  hilar cels is a  decrease  of  dentate  gyrus  output (Hsu et al., 
2016). Since the dentate gyrus is an important input structure to the CA1 via CA3 hippocampal 
regions, it is likely that  CA1 activity could  be  decreased in this  manner.  Therefore, a QNP-
mediated efect on mossy cels and inhibitory cels in the hippocampal hilus may also explain the 
reduction of Arc expression in the CA1 region. 
The last possibility is that reduced Arc expression in the CA1 area is a result of decreased 
excitatory input from upstream structures. In this study we did not look at Arc expression in 
any  of the  upstream structures  of the hippocampus (most  notably the entorhinal cortex and 
subiculum). However, the efect of D2 receptor activation in the cortex is dificult to detangle. D2 
activation has  been  described as both  decreasing (Tseng and  O’Donnel,  2007) and increasing 
cortical  pyramidal excitability (Vitrac et al.,  2014;  Robinson and  Sohal,  2017), and to increase 
cortical inhibition (Xu and Yao, 2010) by diferent mechanisms. It is therefore possible that CA1 
Arc expression is reduced as a result of decreased input to the hippocampus, but it is as likely that 
cortical input is increased folowing QNP administration. Regardless of the exact mechanism, the 
decrease  of  CA1 Arc expression suggests that the overal  hippocampal  output to structures 
downstream of the hippocampus is reduced. 
 
7.3 Carousel arena task learning in QSM 
Next, we observed a reversal learning deficit in QNP treated rats, further supporting the notion of 
functionaly-relevant  hippocampal  hypo-activity in  QNP treated rats.  Specificaly,  QNP treated 
rats showed Carousel arena task acquisition learning comparable with control rats, but displayed 
impaired reversal learning that was not associated with perseverative responding. 
 
7.3.1 Acquisition learning on the Carousel arena in QSM 
QNP treated rats acquired the Carousel  maze task at a similar rate as the control group, despite 
their characteristic  hyper-locomotion observed folowing  QNP treatment. Importantly, the same 
number  of rats  per  group reached the threshold  of  10 erors in a 30min session  by the fourth 
session. This indicates that chronic sensitization of dopamine D2-like receptors by QNP (and their 
ongoing stimulation) does not afect cognitive coordination (perceptual segregation). Our results 
replicate a study conducted in our laboratory that showed that quinpirole does not impair Carousel 
arena task acquisition (Stuchlik et al.,  2007). Yet,  performance  on some  other spatial tasks is 
impaired  by systemic  D2 receptor activation.  For example,  quinpirole  was shown to induce 
cognitive deficits in the Moris Water maze (Cardoso-Cruz et al., 2014). Although D2 availability 
was linked to episodic memory capability in humans (Nyberg et al., 2016), activating D2 receptors 






7.3.2 Reversal learning of the Carousel arena task in QSM 
In the reversal learning, QNP treated rats showed a significant, albeit transient, reversal-learning 
deficit. This reversal  deficit  was  manifested as an increased  number  of erors  during the first 
session after reversal of to-be-avoided sector compared to the control  group. It should be noted 
that this  deficit  was specific  only for the  beginning  of reversal training, since  by the third and 
fourth reversal sessions QNP treated rats displayed a comparable number of erors as the control 
group. The  next section  discusses cognitive  processes that may have  been impaired  during 
reversal in QSM. 
 
7.3.2.1 Dissecting reversal learning deficit in QSM 
It has been proposed that there are three paralel processes that occur during successful reversal 
(Klanker et al., 2013): 
1. Extinction of a response that is no longer rewarded 
2. Response maintenance  
3. Behavioral switch to the new reward/punishment 
If a deficit in extinction causaly impaired reversal in QNP treated rats, a perseverative response 
is expected. However, in our study we actualy observed lower perseveration in rats treated with 
QNP.  However, this lack  of  perseveration is in contrast  with repeated findings that chronic 
administration  of  quinpirole induces perseverative  behavior in alternation tasks (Einat and 
Szechtman,  1995;  Kontis et al.,  2008).  Similarly,  perseverance is indicated by studies 
documenting enhanced ‘compulsive’ lever pressing after repeated administration of QNP (Joel et 
al., 2001). Moreover, in lever pressing task a marked reversal learning deficit was associated with 
a high incidence of perseverative responding folowing QNP administration (Boulougouris et al., 
2009). Despite the oft-reported perseverative behavior, non-perseverative behavior in reversal was 
also observed folowing D2-like manipulation. For example, non-perseverative erors in reversal 
were demonstrated when quinpirole was infused localy into the nucleus accumbens (Haluk and 
Floresco,  2009).  Non-perseverative erors  were also  observed in spatial reversal learning in 
humans after systemic administration  of another  D2-like agonist –  bromocriptine (Mehta et al., 
2001).  Stil, the low  perseveration in  QNP treated rats in  our study is intriguing in light  of 
previous studies that have reported high  perseverative  behavior specificaly in chronicaly  QNP 
treated rats (Kontis et al., 2008; Boulougouris et al., 2009). 
Reversal impairment  due to a defect in a behavioral switch is associated  with 
disorganized behavior (Klanker et al., 2013). Behavioral switches are related to responses to new 
reward/punishment contingencies. Indeed, it  was found that  D2 antagonists facilitate task 
switching while D2 agonists impair behavioral switching (van der Schaaf et al., 2014). 
A defect in response  maintenance is associated  with an inability to improve in  both 
acquisition and reversal tasks (both  between sessions and  within  one session) (Klanker et al., 
2013).  Response  maintenance refers to the persistence  of responding  despite the high effort 
needed to acquire a reward.  Although it  was shown that  mesolimbic  dopamine is  needed to 
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maintain instrumental responding (Fischbach-Weiss et al., 2018), in the light of intact acquisition 
in QNP treated rats this possibility is unlikely. 
The absence  of  perseverative erors and intact acquisition suggest that in QNP treated rats 
deficient  behavioral switching  drives the impaired reversal learning.  Since  both the tonic and 
phasic release of dopamine mediates the valence of reward and punishment (Bromberg-Martin et 
al.,  2010), the deregulation  of  dopaminergic signaling could easily induce the reversal learning 
deficit that was observed in the Carousel arena task. 
One important limitation is that  QNP treated animals could be less sensitive to electric 
shocks. This possibility was not directly tested in our study. However, since acquisition learning 
in  both  QNP treated and control rats were similar, we assume that their sensitivity to electrical 
stimulation is unaltered by QNP treatment. Studies testing a QNP effect on pain sensitivity ofer 
contradictory results, with some studies  proposing analgesic (Roane and  Paul,  1992) and some 
hypo-analgesic effects (Magnusson and  Fisher,  2000;  Munro, 2007).  Lastly, a lesion  of 
dopaminergic projections to the striatum had no efect on escape learning or responses to electric 
shocks, suggesting that intact  dopaminergic transmission is  not  necessary for successful 
avoidance learning (Price and Fibiger, 1975). 
 
7.4 Clomipramine and clomipramine augmented by risperidone in QNP treated 
rats 
In the last two experiments,  we investigated the efects  of commonly  used  pharmacological 
treatments used in OCD  on cognitive flexibility  performance in QNP treated rats.  First, we 
showed a cognitive flexibility  deficit in QNP treated rats.  Second,  we  observed effects of the 
tricyclic antidepressant clomipramine (CMI), the antipsychotic risperidone (RIS), and a 
combination thereof on cognitive coordination and flexibility. We discovered that CMI impaired 
acquisition learning in QNP treated rats. Moreover, we showed that RIS does not ameliorate the 
learning impairment  of  QNP treated rats,  but the administration  of CMI and  RIS together – a 
combination  of  pharmaceuticals  used in  SRI-resistant  OCD patients – ameliorates the reversal 
learning deficit induced by QNP treatment. Last, using a behavioral test that does not require the 
hippocampus,  we  discovered that CMI augmentation in QNP treated rats is specific for the 
hippocampus-dependent Carousel arena task. 
 
7.4.1 A proposed mechanisms of action of the CMI on hippocampal function 
QNP and CMI both inhibit dopamine release from the ventral tegmental area (VTA) in a  direct 
and indirect manner, respectively. Therefore, CMI may potentiate the effects of QNP. Dopamine 
D2 receptors are  present in the VTA as auto-receptors (Li et al.,  196), and it  was shown that 
stimulation  of  D2 receptors  by  quinpirole reduces the firing  of  dopamine (DA)  neurons 
(Koulchitsky et al.,  2012;  Sesia et al.,  2013).  Moreover, serotonin  neurons exert an inhibitory 
efect  on  dopaminergic  neurons in the VTA (Ugedo et al.,  1989), and systemic  SSRI 
administration was shown to decrease VTA dopamine release (Prisco and Esposito, 1995). Thus, 
the addition of CMI to QNP treatment may have decreased dopaminergic tone even further. Since 
the transfer of information from the hippocampus to the PFC is dependent on D1 activity (Goto 
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and  Grace,  2008), a dramatic reduction  of  DA tone could  manifest as  deficient acquisition 
learning in hippocampus-dependent tasks. A reduction of hippocampus–PFC communication, on 
the  other  hand, could  be  beneficial in solving a hippocampus-independent two-way active 
avoidance task since irrelevant spatial information supplied by the hippocampus does not interfere 
with the task. Indeed, it has been shown that lesions of the hippocampus increase the number of 
conditioned escapes, probably by enforcing only a tone-shock association while place information 
(which is irelevant in this task version) is disregarded (Wang et al., 2015). 
 
7.4.2 RIS and CMI co-administration in QNP treated rats rescues reversal learning 
Despite the detrimental efect  of  CMI alone and  no  positive efect  of  RIS alone  when 
administered to QNP treated rats, when CMI and RIS are co-administered, the reversal deficit is 
decreased in QNP treated rats. Offering a potential mechanism of action would be pure conjecture 
given the complexity of the molecular targets of both CMI and RIS. Yet, our findings stil have 
important implications for  OCD treatment.  Risperidone is the most efective antipsychotic 
prescribed to augment the SRI treatment  of  OCD (Dold et al.,  2013), and it is intriguing that 
risperidone augmentation improved reversal learning in an animal  model  of  OCD. It has  been 
proposed that antipsychotics  benefit  patients treated  with antidepressants  because they decrease 
dopaminergic tone (Chernoloz et al.,  2009).  This is in line  with  our  proposed  mechanism  of an 
acquisition learning  deficit after clomipramine augmentation (which could  have aggravated a 
dopamine  neurotransmission reduction). The efectiveness  of clomipramine and risperidone in 
rescuing the reversal deficit in QNP treated rats opens up a possibility that a combination of SRI 
with an antipsychotic may be the best treatment option for OCD patients with cognitive flexibility 
deficits. Based on the consistent checking behavior observed in the enriched open-field arena and 
the reversal deficit in the Carousel arena task we propose that QNP treatment-induced checking 
behavior possibly models a subgroup of OCD patients with a cognitive flexibility deficit. 
 
7.5 Hippocampal dysfunction in OCD? 
Cognitive flexibility deficits have been associated with obsessive-compulsive disorder for a long 
time (reviewed in (Benzina et al., 2016), and the rigid and inflexible behavior characteristic for 
OCD rightly aludes to  deficiencies in  overal cognitive flexibility. Both the over-activity and 
abnormal functioning  of the orbitofrontal cortex (OFC) has often been regarded as a common 
neural substrate of OCD and accompanying cognitive deficits (Remijnse et al., 2006b). However, 
the hippocampus may contribute to both cognitive inflexibility and OCD as wel. 
Hippocampal aberations are implicated in OCD by several studies. Reduced hippocampal 
volume has repeatedly been observed in  patients  with  OCD (Kang et al.,  2003;  Atmaca et al., 
2008;  Reess et al.,  2018).  Shape  deformity  of the hippocampus  was also observed in  OCD 
patients (Hong et al.,  2007).  Moreover,  OCD  patients show abnormal activation  of the 
hippocampus  during reward-based learning (Marsh et al.,  2015) and  during implicit sequence 
learning (Rauch et al., 1997, 2001). Importantly, activity of the right hippocampus was decreased 
after successful SSRI treatment (Kang et al., 2003) and, conversely, was elevated after symptom 
provocation (Adler et al.,  2000).  This could indicate that the hippocampus  may  be  directly 
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involved in the OCD  pathology.  Yet, the implications  of these findings to  OCD are  generaly 
poorly discussed in the literature (Atmaca, 2011). A single theory that considers the hippocampus 
in OCD pathology gives it a role of compensating for deficiencies in procedural memory (Ulman 
and  Pulman,  2015).  However,  given that the hippocampus is  overactive even  during symptom 
provocation (Adler et al., 2000), and that OCD has developed in several cases folowing traumatic 
brain injury localized to the temporal lobe (Max et al., 1995), it is possible that the hippocampus 
is involved more directly in OCD than is curently thought. 
Although  hippocampal aberations  observed in  OCD have  been proposed to  play a 
compensatory role in  OCD (Ulman and  Pulman,  2015),  we  propose that the role  of the 
hippocampus may be causal. CSTC circuits and the hippocampus are involved, in paralel, in the 
generation of responses. The caudate that is most often implicated in OCD, is involved in habitual 
response-based learning,  while the nucleus accumbens (ventral striatum) and  hippocampus are 
implied in flexible goal-directed behaviors. In a seminal study by Packard and McGaugh, a lesion 
to the caudate resulted in a goal directed response while a lesion to the hippocampus resulted in a 
stereotypical response in a T-maze task (Packard and McGaugh, 1996). In this light, hippocampal 
deficiency could lead to the overt activity of CSTC circuits involving the caudate – such as the 
orbitofrontal circuit. In line with this, hippocampal insuficiency in QNP treated rats could also 
result in stereotypical behavior.  Hyperactivity in the orbitofrontal  CSTC circuit could thus be a 
compensation  of  hippocampal  deficiency  – not a cause. Studies exploring a causal role  of the 
hippocampus in the generation of stereotypical checking in QSM are curently under way in our 





One  goal of this  work is to  point to  new potential  directions in the research on Obsessive 
Compulsive Disorder. Alterations in hippocampal shape and function have often been reported in 
literature, but  were  not  given  much atention. In  our research,  we may  have stumbled  onto an 
important aspect of OCD. Although our findings are solely correlational, we have discovered that 
an impaired hippocampal state is associated with stereotypical checking and cognitive inflexibility 
– both halmarks of OCD. Namely, we found the reduced expression of the immediate-early gene 
Arc (a marker of plasticity-related neuronal activity) in the main hippocampal output region – the 
CA1. Also, at the level of behavior, we found impairment in a hippocampus-dependent task and 
superior performance in a hippocampus-independent task in the QNP sensitization model of OCD. 
These complementary findings warrant further research to show causality and the implementation 
of  more complex reversal tasks to chalenge cognitive inflexibility in OCD  patients. Research 
along both of these paths is curently underway in our laboratory. We wil apply QNP directly to 
the hippocampus in QNP-treated animals and assess stereotypical checking in the enriched open-
field arena. Also, OCD patients are being tested in a virtual analog of the Carousel arena task (by 
Iveta Fajnerova, Ph.D. from National Institute of Mental Health). The present study also assessed 
the efects  of common  drugs  prescribed to OCD  patients – clomipramine, risperidone and the 
combination thereof – on cognitive flexibility in the QNP sensitization animal model of OCD. We 
found that the combination of clomipramine and risperidone may be the most efective in rescuing 
QNP induced cognitive deficits, as acquisition and reversal performance were spared in animals 
receiving this treatment.  We  propose that  QNP sensitization could  model a subgroup  of  OCD 
patients  with cognitive flexibility  deficits stemming from  hippocampal  dysfunction.  We further 
suggest that this subgroup of patients may benefit most from the augmentation of SRI treatment 
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